<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://www.nal.usda.gov/exhibits/speccoll/items/browse?advanced%5B0%5D%5Belement_id%5D=39&amp;advanced%5B0%5D%5Btype%5D=is+exactly&amp;advanced%5B0%5D%5Bterms%5D=Shepard%2C+Barclay+M.&amp;output=omeka-xml" accessDate="2026-09-12T11:51:55+00:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>15</perPage>
      <totalResults>7</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="6014" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="45310">
              <text>166</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="45311">
              <text>4947</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="45313">
              <text>Series VII</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="45309">
                <text>Shepard, Barclay M.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="45312">
                <text>Memorandum: from Barclay M. Shepard with subject VA Publications of Scientific Literature on Herbicides, January 1987</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="3292" public="1" featured="0">
    <fileContainer>
      <file fileId="1702">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/b677371336f0a60017b46af9dd5a1d6f.pdf</src>
        <authentication>a3e56005c1947ba2597cabb4591043d8</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63651">
                    <text>Item ID Number

01868

Author

Shepard, Barclay M.

Corporate Author
ROpOTt/ArUdO TltlB Critique of West Virginia Mortality Study

Journal/Book Title
Year

1986

Month/Day

February 4

Color

a

Number of Images

36

UOSCrtytOn NOtBS

ltem inlcudes

critique, as well as attached 1) M. L.
Neighbors Diversified Maritime Services, Inc.
advertisement and 2) Vietnam-Era Veterans Mortality
Study, West Virginia Residents 1968-1983, Preliminary
Report, January 1986.

Wednesday, July 11, 2001

Page 1869 of 1870

�FEB 04 1986
Critique of West Virginia Mortality Study

The West Virginia Department of Health has recently completed a
mortality study (copy attached) of Vietnam-era veterans based on the
recipients of a state bonus. The State offered a differential bonus
to all West Virginia residents who served in the military during the
Vietnam era with a larger amount going to those who served "incountry". 41,059 in-country (Vietnam veterans) and 41,782 non-incountry (non-Vietnam) veterans received the bonus. The list of bonus
recipients was matched against state vital statistic records
resulting in 1225 male Vietnam-era veterans who had died between 1968
and 1983. For each deceased male veteran a copy of the Report of
Separation From Active Duty (DD 214) was reviewed to determine dates
and place of service. The latter was determined by receipt of at
least one of the three medals awarded for service in the Southeast
Asia theater of operations. In addition, cause of death information
was obtained on each deceased veteran. Of the 1225 deceased
veterans, 615 were in the group of Vietnam veterans and the remaining
610 were non-Vietnam veterans, i.e., veterans who served elsewhere
during the same period of time. When comparing causes of death
between all veterans in the group and non-veterans of similar age
only those classified as accidents, poisoning, and violence were
elevated among the veteran group. Deaths due to cancer were
statistically the same in both groups. Other causes of death were
lower in the veteran group, a commonly observed phenomenon known as
the "healthy veteran effect".
A stated by the authors, the study has a number of limitations which
must be kept in mind when interpreting the results:
"In spite of the intense publicity given to the bonus campaign,
it is likely that many veterans or their survivors never applied
for the bonus. Thus, those veterans who did qualify for a bonus
represent an unknown proportion of the actual number of West
Virginia males'who served in the military during the Vietnam
era. It cannot be assumed that the proportion was similar for
both [groups]. Furthermore, because the mortality tape
identified only residents of West Virginia who died during the
study period, deaths in that period among veterans who no longer
resided in West Virginia at the time of their demise would not
have been counted among the 1,225 veterans deaths ascertained.
. . With respect to a comparison between in-country and era
.
veterans, it cannot be assumed that similar proportions of the
respective candidate population qualified for the bonus or that
the death rates among in-country veterans who were no longer
West Virginia residents were similar to those among era veterans
who were no longer residents."

�There were 145 cancer deaths of which 71 were in the group of
Vietnam veterans and 74 were among the non-Vietnam veterans. In
comparing specific types of cancers between these two veteran
groups, only Hodgkin's disease, testicular cancer, and soft tissue
sarcoma were elevated in the Vietnam veteran group. In each
instance, however, the number of actual cases was small, i.e., 5
cases of Hodgkin's disease, 3 testicular cancers and 3 soft tissue
sarcomas. As the authors state: "These findings must be
interpreted cautiously ... since ... the site- specific cancer
deaths were derived from a relatively small number . . and would
.
therefore be subject to ... large random fluctuations".
In addition to the stated limitations of the study, as pointed out
by the authors, there has been no systematic review of military
personnel records, except for the DD 214 reviews as noted above, to
validate the Vietnam service status of the study subjects. Because
of the interest and concern over the relationship between soft
tissue sarcoma and exposure to the phenoxy herbicides, the authors
have now requested a review of the personnel records of the 3
veterans recorded as having this diagnosis. All.three of these were
reported to have occurred in the in-country veteran group. The
first of these is now known to have served in Thailand, not Vietnam,
and would not have been exposed to Agent Orange. This is an example
of the serious effect of misclassification especially when dealing
with small numbers of subjects. In addition, there has been no
systematic review of hospital or other clinical records to validate
cause of death information or confirm the specific cancer diagnosis.
Again, when dealing with relatively small numbers, a few errors in
diagnosis can significantly alter the conclusions.
In summary, this study appears to have been well designed and well
conducted as far as it goes. As noted by the authors, however, it
has inherent limitations and additional data are needed to validate
some of the conclusions.

BARCLAY M. SHEPARD, M.D.

Director, Agent Orange Projects Office

�«J£.

tLAet&amp;Ad&amp;Ht-

1 January 1986
ANNOUNCEMENT
M. L. NEIGHBORS, DIVERSIFIED MARITIME SERVICES, INC., announces
that it is now able to offer part time consultative service or
representation in the Washington, DC area to additional firms or
persons that are engaged or have an interest in maritime related
business ventures or business involving the disposal of chemical
waste. Such work may also be arranged for in locations other than
the Washington DC area as mutually agreed, and on either a prime or
sub-contract basis.
Among services offered are:
A. Maintaining continuous contact with federal agencies
having jurisdiction or control over maritime or chemical waste
disposal ventures, and submittal of reports on matters of client
interest. Rapid "feed-back" on specific information of more
urgent interest can also be provided.
B. Projection of U.S. chemical waste disposal requirements,
in general or with specificity.
C. Assisting in the initiation of either a maritime project
or a project involving chemical waste disposal (except services
involving the disposal of chemical waste by incineration at sea
cannot be provided until after 30 November, 1986).
CORPORATE EXPERIENCE INCLUDES:
Nineteen years involvement with Department of Defense vessel
charters and military cargo movement contracts.
Thirteen years involvement with various offices of the
Environmental Protection Agency that are responsible for
regulating chemical waste disposal. This work included interaction with other federal agencies and with commercial firms
offering alternative types of chemical waste disposal service.
Written inquiries should be addressed to M. L. Neighbors, DMS
Inc., 777 Fourteenth St., Suite 747, Washington, DC, 20005.
Further information may also be obtained from Mr. Neighbors at
phone number 564 1568 (area code 301 if calling from outside
metro area).

�WEST VIRGINIA HEALTH DEPARTMENT

�VIETNAM-ERA VETERANS MORTALITY STUDY
WEST VIRGINIA RESIDENTS

1968 - 1983

Preliminary Report

January 1986

Arch A. Moore, Jr.
Governor

David K. Heydinger, M.D.
Director, Department of Health

�Alan P. Holmes, B.S.E.E., M.B.A.
Principal Investigator

WEST VIRGINIA DEPARTMENT OF HEALTH
VIETNAM-ERA VETERANS MORTALITY STUDY COMMITTEE

Charles Bailey
Assistant Director, Health Statistics Center
Roy C. Baron, M.D., M.P.H.
Medical Epidemiologist
Edward Bosanac, Ph.D.
Research Consultant
John Brough, Dr. P.H.
Director, Preventive Health Services
Charles Conroy, M.A.
Agent Orange Program Coordinator
Acting Director, Community Health Services
Loretta Haddy, M.A., M.S.
State Epidemiologist
Alan P. Holmes, M.B.A.
Director, Health Statistics Center

ACKNOWLEDGEMENTS

Sandra Y. Pope, Administrative Assistant, Agent Orange Program
Eugenia Thoenen, Publications Coordinator, Health Statistics Center
Thomas N. Leonard, Programmer/Analyst, Health Statistics Center
Betty Jo Berry, Secretary, Health Statistics Center
We would also like to thank Col. John W. Moon and the staff of
, the West Virginia Department of Veterans' Affairs for their
invaluable assistance in providing data used in this study.

For further information, contact
Charles Conroy, Agent Orange Program Coordinator
1800 Washington Street, East
Charleston, WV 25305
Telephone: (304) 348-3210

�Vietnam-Era Veterans Mortality Study
West Virginia Residents 1968-1983

The Agent Orange Assistance Program, established in 1982 by
the West Virginia legislature, requested the Health Statistics
Center of the Department of Health to conduct a study of the
causes of death among state Vietnam veterans from 1968 through
1983.*

The purpose of the study was to compare the mortality

pattern among veterans with that of nonveterans

in order to

generate hypotheses regarding any differences in the causes of
death among the former. A comparison of the causes of death among
veterans who served in Vietnam with those among veterans who did
not serve in Vietnam was also undertaken in order to speculate
whether

the Vietnam

experience

might

be

associated

with a

distinct mortality pattern.

METHODS

Identification of West Virginia Veterans

West Virginia residents who served in the military during
the years of the Vietnam Conflict were identified from the list

*The Vietnam era is generally defined as extending from 1964
until 1973. For the purposes of this study, however, only those
deaths from 1968 were considered because of the small number of
deaths occurring before that year, in addition to difficulties
imposed by cause-of-death coding changes over the longer
interval.

�of applicants for a military service bonus offered by the state
Department of Veterans' Affairs in 1974.

To qualify for a bonus,

veterans had to meet the following criteria:
1) they must have rendered active service in the armed
forces at some time between August 1, 1964, and March
28, 1973, inclusive, or have been recipients of the
Vietnam armed forces expeditionary medal if they saw
active service prior to August 1;
2) they must have been residents of West Virginia for at
least six months prior to entry into active service;
3) they must have actively served for a period of at least
ninety days unless discharged because of a servicerelated disability, and
4) they must have been honorably discharged.
Efforts to notify eligible veterans or their survivors about
the bonus program included one national public awareness campaign
conducted in November 1975 and one conducted in July 1976.
Public service announcements were issued over the television
networks, and notices were posted in every major newspaper in the
country

and

organizations

on

service

advertised

networks

the

bonus

overseas.
legislation

Veterans'
in

their

publications, and some offered assistance in filing for the bonus
as a promotional device in their membership campaigns.

Three different bonuses were offered. Veterans who did not
serve in Vietnam

("out-of-country" or era veterans) were to

receive up to $300 (Type 3 bonus); Vietnam veterans ("in-country"
veterans) were

to receive

up to $400

(Type 4 bonus), and

surviving relatives of veterans who died while in the service
during the period designated by the legislature were to receive

�$500 (Type 5 bonus).

In West Virginia,

the Department

of Veterans'

reported a total of 86,247 initial applicants.

Affairs

Of those who

applied for the bonus, 83,730 veterans or survivors (97%) were
eligible (Figure 1).

Of these, 41,782 qualified for the Type 3

(Vietnam-era) bonus, 41,059 qualified for the Type 4 (Vietnam)
bonus, and 889 qualified for the Type 5 bonus.

Since this was to

be a study of mortality following discharge from the service, the
Type 5 bonus recipients were excluded from subsequent analyses.
Names of the Type 3 and Type 4 qualifiers were, entered onto a
computer tape, referred to as the "bonus tape."

Identification of Veteran and Nonveteran Deaths

A complete listing of West Virginia resident deaths from
1968 through 1983 was prepared from records maintained by the
Health Statistics Center and entered onto a "mortality tape."
The

names

on

this

list were then compared with those on the

bonus tape in order to identify veterans who died during this
period.

For deaths from 1968 through 1978, the information had

to be matched by name since social security numbers were not
included on the mortality tape for these years.

Any possible

match generated in this manner was searched by hand and confirmed
by comparing the social security number on the death certificate
with that on the veteran application.

From 1979 through 1983, it

was possible to match by social security number.

�FIGURE 1
WV VIETNAM VETERAN MORTALITY STUDY
SELECTION OF STUDY POPULATION
1968-83

Bonus Tape
83,730

1

1

1
In -Country
Vietnam
41,059

Not-in-Country
Era
41,782

No-Match
Death File
41,169

Females

Era
3

Nonwhite
Males
Era
30

MatchedDeath File
Era
613

Males
Era
610

White
Males
Era
580

No-Match
Death File
40,444

Died in
Service
889

MatchedDeath File
Vietnam
615

Females
Vietnam
0

Males
Vietnam
615

Nonwhite
Males
Vietnam
36

White
Males
Vietnam
579

�There were 1,234 initial matches between the bonus tape and
the mortality tape, 614 Vietnam-era (Type 3) veterans and 620
in-country

(Type

4) veterans.

The veterans' discharge forms

(DD-214s) were then manually checked to verify their in-country
status.*

This

review

reclassification

of

resulted

several

in

records,

the

deletion

leaving

1,228

and/or
deceased

veterans who qualified, 613 for the Type 3 bonus and 615 for the
Type 4 bonus.

Three of the deceased veterans, all Type 3 bonus

recipients, were female.

They were excluded from the final tape;

the subsequent analyses included only deceased male veterans.

Of the 1,225 male veterans who died (Table 1), 1,159 were
white and 66 were nonwhite (65 black and 1 Hawaiian).
nonwhite veterans were Type 3 (5%) and 36 were Type 4

Thirty
(6%).

Because nonwhite veterans constituted a small percentage of those
who died, the study combined the mortality patterns of white and
nonwhite veterans.

For

nonveteran males,

deaths were

identified

from the

mortality tape by deleting the records of all remaining female
deaths and those of the 1,225 male veteran deaths.
thus four groups defined for analysis:
died; (2) male

Vietnam-era-only

There were

(1) all male veterans who

(Type 3)

veterans

who

died;

*In-country status was determined by the receipt by the
veteran of one of three service medals (the Vietnam service medal,
the Vietnam campaign medal, or the Vietnam expeditionary medal) as
noted on the DD-214. These medals were awarded to military
personnel who served in the Southeast Asia theater of operations.

�TABLE 1
TYPE 3 AND TYPE 4
MATCHES BETWEEN BONUS TAPE AND MORTALITY TAPE
BY YEAR
1968-83

YEAR

VIETNAM-ERA
(Type 3)

IN-COUNTRY
(Type 4)

TOTAL

1968

4

13

17

1969

14

16

30

1970

17

22

39

1971

16

33

49

1972

26

31

57

1973

33

22

55

1974

25

29

54

1975

50

47

97

1976

47

46

93

1977

50

40

90

1978

54

35

89

1979

53

44

97

1980

58

51

109

1981

53

70

123

1982

55

59

114

1983

56

56

112

TOTAL

610

615

1,225

�(3) male in-country (Type 4) Vietnam veterans who died, and (4)
all

other West

Virginia

males

(nonveterans) who

died

from

1968-83.

DEMOGRAPHIC PROFILE OF DECEASED VETERANS

Age Distribution

The average age at death was 35.3 for all veterans, 35.1 for
era veterans and 35.4 for in-country veterans.

Table 2 shows

that the distribution of deaths by age for Type 3 and Type 4
veterans was similar.

Tables 3 and 4 present the distributions of age at death by
race for Vietnam-era and Vietnam veterans, respectively.

Among

white Type 3 veterans, the average age at death was 35.3, among
nonwhites 31.3. For Type 4 veterans, the mean age at death for
whites was 35.5, with 33.5 that for nonwhites.

�TABLE 2
ALL VIETNAM-ERA VETERANS
Age Distribution by Type of Service

VIETNAM-ERA
(Type 3)

TOTAL

IN- COUNTRY
(Type 4)

AGE GROUP

f

%

%

*

4

I

15-19

4

0.7

1

0.2

5

0.4

20-24

82

13.4

92

14.9

174

14.2

25-29

139

22.8

125

20.3

264

21.5

30-34

137

22.4

143

23.2

280

22.9

35-39

83

13.6

61

9.9

144

11.7

40-44

42

6.9

53

8.6

95

7.7

45-49

36

5.9

60

9.8

96

7.8

50-54

40

6.6

33

5.4

73

6.0

55-59

24

3.9

32

5.2

56

4.6

60-64

12

2.0

12

2.0

24

2.0

65-69

9

1.5

3

0.5

12

1.0

70-74

2

0.3

0

0.0

2

0.2

TOTAL

610

100.0

615

100.0

1,225

100.0

Average Age
at Death

35.4

35.1

8

35.3

�TABLE 3
VIETNAM-ERA VETERANS (TYPE 3)
Age Distribution by Race

WHITE

TOTAL

NONWHITE

AGE GROUPS

%

#

%

#

%

1

19

4

0.7

0

0.0

4

0.7

20-24

77

13.3

5

16.7

82

13.4

25-29

131

22.6

8

26.7

139

22.8

30-34

127

21.9

10

33.3

137

22.4

35-39

79

13.6

4

13.3

83

13.6

40-44

42

7.2

0

0.0

42

6.9

45-49

33

5.7

3

10.0

36

5.9

50-54

40

6.8

0

0.0

40

6.6

55-59

24

4.2

0

0.0

24

3.9

60-64

12

2.1

0

0.0

12

2.0

65-69

9

1.6

0

0.0

9

1.5

70-74

2

0.3

0

0.0

2

0.3

TOTAL

580

100.0

30

100.0

610

100.0

Average Age
at Death

35.3

31.3

35.1

�TABLE 4
IN-COUNTRY VIETNAM VETERANS (TYPE 4)
Age Distribution by Race

NONWHITE

WHITE

TOTAL

AGE GROUPS

%

#

#

%

t

Z

19

0

0.0

1

2.8

1

0.2

20-24

87

15.0

5

13.8

92

14.9

25-29

114

19.7

11

30.5

125

20.3

30-34

135

23.3

8

22.2

143

23.2

35-39

59

10.2

2

5.6

61

9.9

40-44

51

8.8

2

5.6

53

8.6

45-49

59

10.2

1

2.8

60

9.8

50-54

29

5.0

4

11.1

33

5.4

55-59

30

5.2

2

5.6

32

5.2

60-64

12

2.1

0

0.0

12

2.0

65-69

3

0.5

0

0.0

3

0.5

70-74

0

0.0

0

0.0

0

0.0

TOTAL

579

100.0

36

100.0

615

100.0

Average Age
at Death

35.5

33.5

10

35.4

�Branch of Service

Review of the DD-214 forms showed that 718 (59%) of the
deceased veterans had served in the army, 210 (17%) had served in
the air force, 167* (14%) had served in the navy, and 120 (10%)
had served in the marines (Table 5).

Seventy-five percent of the

in-country veterans who died had been in either the army or the
marines, in contrast to 62% of the era veterans.

Twenty-five

percent of in-country veterans had served in either the air force
or the navy, in contrast to 37% of, the era veterans.

For 10

veterans, the branch of service was not recorded on the discharge
forms.

*Includes 3 coast guard veterans.

11

�TABLE 5
ALL VIETNAM-ERA VETERANS
Branch of Service by Type of Service
VIETNAM-ERA
(Type 3)

IN-COUNTRY
(Type 4)

TOTAL

BRANCH OF SERVICE

%

*

t

%

*

%

Army

340

55.7

378

61.5

718

58.6

Air Force

127

20.8

83

13.5

210

17.2

16.1

69

11.2

167

13.6

Navy

98*

Marines

39

6.4

81

13.2

120

9.8

Unknown

6

1.0

4

0.6

10

0.8

610

100.0

615

100.0

TOTAL

*Includes
3 coast
guard
veterans

12

1,225

100.0

�ANALYTIC METHODS

In

spite

of

the

intense publicity

given to the bonus

campaign, it is likely that many veterans or their
never

applied

for the bonus.

survivors

Thus, those veterans

who did

qualify for a bonus represent an unknown proportion of the actual
number of West Virginia males who served in the military during
the Vietnam era.

It cannot be assumed that the proportion was

similar for both Type 3 (era) and Type 4 (in-country) qualifiers.
Furthermore, because the mortality tape identified only residents
of West Virginia who died during the study period, deaths in that
period among veterans who no longer resided in West Virginia at
the time of their demise would not have been counted among the
1,225 veteran deaths ascertained.

Because of these limitations, the records provide neither
complete information about the total candidate population nor a
comprehensive

estimate

of the force

veterans who did qualify.
the

veteran

and

the

of mortality

among

the

With respect to a comparison between
nonveteran

groups,

the

data

would

underestimate the relative force of mortality among the veterans,
if such a comparison were made.

With respect to a comparison

between in-country and era veterans, it cannot be assumed that
similar

proportions

of

the

respective

candidate population

qualified for the bonus or that the death rates among in-country
veterans who were no longer West Virginia residents were similar
to those among era veterans who were no longer residents.

13

�The method of choice for a study of mortality when there is
incomplete data on the population at risk is a proportionate
mortality analysis.

In this type of study the proportion of all

deaths due to the disease(s) of interest in the study population
is

compared with

the proportion of all deaths due to the

disease(s) of interest in the comparison (referent) population.
Such proportional rates do not express the risk of dying from a
disease since the incidence is not measured against a population
base.

They simply suggest that there may be a difference worth

investigating further.

The validity of such a study rests on the

assumption that there is no association between the study factor,
i.e.,

veteran

status, and the occurrence of other diseases.

Since we cannot make this assumption, such an analysis is used to
generate hypotheses or to conduct preliminary tests of etiologic
hypotheses without collecting much additional data.

The relationship between the proportion of deaths due to a
specified cause in a study population and the proportion derived
from the referent population is expressed as a proportionate
mortality ratio (PMR).

The PMRs in this study are standardized

to adjust for selected confounding variables.

When the veteran

group and its subgroups were compared with the nonveteran group,
adjustments were made by stratifying on age at death by 5-year
intervals (15-19, 20-24, . . . etc.) and on year of death by
2-year intervals
stratum,

(1968-69, 1970-71,

expected deaths were

. . . 1982-83).

For each

calculated by determining

the

percentage the cause of death of interest contributed to all

14

�causes in the referent population and multiplying this result by
the total deaths from all causes in the study population.

The

standardized PMR statistic (sPMR) is the ratio of the number of
deaths of interest observed in the study population summed over
all strata, multiplied by 100, and then divided by the expected
values summed over all strata.

Stratification by age only and

not by year of death was done when the in-country (study) group
of veterans was compared to the era (referent) group.

This was

done in order to avoid losing data from the study group when
respective strata in the referent group had no deaths.

An sPMR

greater than 100 indicates that the cause of interest contributes
a greater percentage of all deaths in the study population than
in the referent population; an sPMR less than 100 indicates that
the cause contributes a smaller percentage of all deaths in the
study population than in the referent population, and an sPMR of
100 indicates that the cause of interest contributes the same
percentage of all deaths in both groups.
expected frequencies
against

confidence
p-value

for each cause of interest were tested

the null hypothesis, i.e.,

proportionate

mortality

interval

expressing

The observed and

structure,

around
the

each

each

exact

sPMR

by

group has the same
calculating

a

95%

and also a one-tailed

probability

of

finding

the

difference between the observed and expected frequencies.
RESULTS

In the period 1968 through 1983, there were 1,225 deaths
among males who had served in the military during the Vietnam

15

�Conflict.

Six hundred fifteen of the men served at least a

portion of their duty in Vietnam (in-country, Type 4 veterans)
and 610 had no experience in Vietnam (era, Type 3 veterans). For
both groups combined, 716 deaths (58%) were from external causes
(injury from accidents, poisoning, or violence), 237 (19%) were
from

cardiovascular

neoplasms,

48

(4%)

disease,
were

145

from

(12%)

were

nonmalignant

from
diseases

malignant
of the

gastrointestinal system, 24 (2%) were from nonmalignant diseases
of

the

respiratory

system,

5

(-=1%) were

from allergic,

metabolic, and endocrine disorders, and 50 (4%) were from all
other causes.

With nonveteran West Virginia male deaths from 1968 through
1983 as a reference, Table 6 demonstrates the number of observed
and

expected

deaths

in

each

cause-of-death category for all

veterans together and for in-country and era veterans separately.
For all veterans, the observed distribution of deaths over these
categories was significantly different from the expected (Chi
square

Goodness

of

Fit •» 50.2

with

6 degrees of

freedom,

p&lt;10~8).

Accidents,
significantly

poisoning,

greater

and

proportion

violence
of

accounted

all veteran

for

a

deaths than

expected (sPMR excess), while deaths from allergic, metabolic,
and endocrine conditions and from all other causes accounted for
significantly smaller-than-expected
deaths

(sPMR

deficits).

For

16

proportions of all veteran

cardiovascular, digestive, and

�TABLE 6
ALL CAUSES OF MORTALITY
Vietnam Veterans vs. Nonveterans
West Virginia, 1968-83
ALL VETERANS
vs.
NONVETERANS

IN- COUNTRY VETERANS
vs.
NONVETERANS

ALL CAUSES

°/.
Accidents, Poisoning,
and Violence
(80E9)
E0-99

716,
'626.74

Cardiovascular Disease
(9-5)
3049

237,
'251.5

Malignant Neoplasms
(140-209)

sPMR

(95Z CI)

°/
'E

sPMR

ERA VETERANS
vs.
NONVETERANS

(95Z CI)

°
/

sPMR

(95Z CI)

(106-130)

354,
'318.1

111*

(100-124)

'E

(106-123)

362.
'308.6

117**

94

(83-107)

114,
'129.1

88

(73-106)

123,
'122.4

100

(84-120)

145,
'142.4

102

(86-120)

71,
'73.6

96

(75-122)

74,
'88
6.

108

(85-136)

Diseases of the
Digestive System
(520-577)

48,
'56.7

85

(62-112)

29,
'29.0

100

(67-144)

19,
'27.8

68

(41-107)

Diseases of the
Respiratory System
(460-519)

24.
'29
3.

73

(47-108)

12,
'16.7

72

(37-125)

12,
'16.2

74

(38-129)

38*

(10-96)

52**

(33-77)

114**

y

Allergic, Metabolic,
and Endocrine Diseases
(240-279)
All Other Causes
(Residual)

'19
2.

50.
'29
9.

23**

(7-53)

'll.2

9**

(-=1-47)

'06
1.

54**

(40-71)

26.
'68
4.

56**

(36-81)

24,
'61
4.

Goodness of Fit X2. -50.2
odt
p- 1 '
08
*polsson p value*.05
**poisson p value£.001

�respiratory diseases, the standardized proportionate mortality
ratios were less than unity when all veterans were compared with
nonveterans,

but

the

observed

numbers

of

deaths

in these

categories were not significantly lower than the expected.
proportion of veteran

The

deaths due to malignant neoplasms was

similar to that of nonveterans.

The pattern

of death

for

in-country

and era

veterans

evaluated separately relative to the nonveteran population was
similar in both instances to the pattern observed for the groups
combined.

In a separate contrast with era veteran deaths as the

standard (not shown), no difference was. observed in the overall
mortality pattern between in-country and era veterans (Chi square
Goodness of

Fit = 7.0 with

5 degrees

of

freedom, p - .22).

In order to evaluate more specific causes of death within
the leading categories, the contrasts were repeated to obtain
standardized proportionate category-specific mortality ratios for
external causes (injury), cardiovascular diseases, and malignant
neoplasms separately.

Table 7 shows the distribution of injury

deaths for veterans contrasted with nonveterans over five causes:
motor vehicle accidents, non-motor-vehicle accidents, suicide,
homicide, and all other external causes.

Homicide accounted for

a significantly smaller-than-expected proportion of the injury
deaths among veterans.

The standardized proportionate injury

mortality ratio for motor-vehicle-related deaths among veterans
was greater than 100 but was not a statistically significant

18

�TABLE 7
INJURY MORTALITY
Vietnam Veterans vs. Nonveterans
West Virginia, 1968-83
ALL VETERANS
vs.
NONVETERANS
°
/

sPMR

(95Z CD

315,
'9.
206

108

(97-121)

201,
'0.
293

96

(83-110)

104

(85-125)

ACCIDENTS. POISONING,
AND VIOLENCE
(E800-999)
Motor Vehicle
(E810-E825)
Ron-Motor Vehicle
(E800-E809,
E826-E949)
Suicide
(E9SO-E9S9)
HoBiclde
(E960-E969)
All Other Causes
(E970-E999)

IN-COUNTRY VETERANS
vs.
NONVETERANS

'E

111

'107.2
63.
'81.5

77*

(59-99)

26.
'74
2.

95

(62-139)

Goodness of Fit X^.--6.78

P-.15
*poisson p value-=.05

sPMR

107

(115
9-2)

100,
'105.1

95

(77-116)

111

(85-144)

sPMR

(95Z CI)

154.
'4.
105

110

(318
9-2)

101,
'0.
142

97

(79-118)

/
'54.2

96

(72-126)

35,
'14
4.

85

(59-118)

87

(45-152)

(95Z CI)

161,
'5.
101

ERA VETERANS
vs.
NONVETERANS

°'E
/

5
9

/
'53.0

28.
'02
4.
1
4

/
'13.6

70*

103

(46-101)

(56-173)

Goodness of Fit XJ^-5.43

P-.25

°'E
/

5
2

12

/
'38
1.

Goodness of Fit X2df-2.71

p-,61

�excess.

For non-motor-vehicle fatalities, suicide, and all other

causes, the expected numbers were similar to the observed.

The

overall pattern for veterans was not significantly different from
nonveterans (Chi square Goodness of Fit » 6.78 with 4 degrees of
freedom, p =.15).

Separate comparisons of the in-country and era

veteran populations

with

nonveterans

similarly

overall difference in the distribution

reflected no

of injury deaths; the

ratios in each of these contrasts were similar to those observed
for the combined veteran group.

Among the cardiovascular causes of mortality
there

were

no

veteran

deaths

from

either

(Table 8),

hypertension or

rheumatic heart disease (p-=.005), fewer-than-expected veteran
deaths from cerebrovascular disease (difference not significant),
and

more-than-expected veteran deaths due to ischemic heart

disease

(difference

standardized

not

significant).

proportionate

cardiovascular

The

individual

disease

mortality

ratios for in-country and era veterans were similar to the
corresponding mortality ratios derived for the combined group.

Proportionate cancer mortality ratios comparing veterans to
nonveterans are shown in Table 9.
veterans

and

respiratory

the
system

nonveteran

excess

contributed

population,

accounted

proportion of veteran cancer
by

In the comparison between all

for

deaths

in-country

identical to that contributed by

20

a

era

neoplasms

significantly
than

of

greater

expected.

veterans
veterans.

was

the

The

virtually

Melanoma of

�TABLE 8
CARDIOVASCULAR DISEASE MORTALITY
Vietnam Veterans vs. Nonveterans
West Virginia, 1968-83
ALL VETERANS
vs.
NONVETERANS
CARDIOVASCULAR DISEASES
(390-459)
Ischemic Heart Disease
(410-414)

Cerebrovascular Disease
(430-438)

°/.

sPMR

(95Z CI)

158.
'141.5

112

(95-131)

18,
'50
2.

72

(43-114)

Hypertension
(400-405)

°65
'.

Rheumatic Heart Disease
(390-398)

°/5.4

All Other
Cardiovascular Diseases
(415-429, 440-459)

IN-COUNTRY VETERANS
vs.
NONVETERANS

61

'86
5.

0**

0**

104

*poisson p valuer .05
**poisson p value «.005

°/

'E

sPMR

(95Z CI)

°'E
/

sPMR

(952 CI)

/
'67.7

111

(87-139)

83,
'40
7.

112

(89-139)

73

(32-144)

10,
'40
1.

71

(34-131)

75

8

/
'09
1.

-

°/3.4

0*

-

°&gt;1.9

0

/
'30.2

103

(80-134)

ERA VETERANS
vs.
NONVETERANS

31

-

°/3.0

0*

-

°/3.5

0*

(70-146)

30

'84
2.

106

-

(71-151)

�TABLH. »
CANCER MORTALITY

Vietnam Veteran* vs. Nonveterans
West Virginia. 1968-83
IN-COUNTRY VETERANS
vs.
NONVETERANS

ALL VETERANS
vs.
NONVETERANS
MALIGNANT NEOPLASMS
(140-209)

sPHR

(951 CD

135*

(102-174)

123

(91-162)

462*

(6-9)
1897

21,
'69
2.

78

(819
4-1)

12,
'.
66

182*

(94-318)

79

(38-145)

6

128

(46-276)

7

123

(50-254)

°&gt;E

Respiratory System
"4.
'31
(160-163)
Trachea, Bronchus, 50
and Lung
'07
4.
(162)
Larynx
(161)
Digestive Organs
and Peritoneum
(150-159)

to
to

Malignant Melanoma
of the Skin
(172)
Lymphoms
(200-203, 208-209)

'13
'.

10

/
'12.7

Hodgklns Disease
(201)

/4.7

Hale Genital Organs
(185-187)
Leukemia
(204-207)

&gt;,.7

6

/13.1

3

/0.7

%

sPHR

(951 CD

131*

(87-187)

29,
'09
2.

139*

(93-199)

118

(76-174)

25.
'19.5

128

(83-189)

49
2*

(95-1349)

49
2*

(95-1349)

77

(37-142)

% 7
.

4

148

(40-378)

%9
.

205*

(89-406)

7

&gt;6.2

113

(45-233)

% 4
.

47

(10-136)

% 4
.

208

(69-497)

&gt;/2.4

42

(1-233)

4

182

(49-461)

%*
.

83

(18-254)

(17-100)

3

48

(10-139)

V.

44

(9-129)

(36-334)

2

/1.4

143

(17-508)

2

118

(5-435)

(11-102)

'41
/.

24

(-1-137)

3

51

(10-148)

250

(52-731)

% 7
.

429*

(90-1271)

200

(5-1071)

46*

129

*/10

Soft and Connective
Tissue
(171)

3

Bone
(170)

2

/K4

143

(18-531)

Urinary Organs
(188-189)

2

/5.6

36

(4-129)

/15.6

103

(59-166)

16

/
'21.2

(951 CD

10,
'13.0

Brain i Nervous System
(191-192)

All Other Halfgnancle.

25

sPNR

(911
3-4)

4

/1.2

29,
'22.2

NONVETERANS

79

Oral Cavity
(140-149)

&gt;3.1

°&gt;E

ERA VETERANS

40*

•polaaon p value*.05

11,
'14.0

/2.7

/2.2

/6.3

'05
'.

V,

'77
'.

0*

78

/1.7
/5.9

°OS
'.

V
.
2

-

(29-170)

'.
27

' ,
V

0

-

125

(3-663)

74

(10-305)

127

360-231)

�TABLE 10
CANCER MORTALITY FOR VIETNAM VETERANS

In-Country Veterans vs. Era Veterans
West Virginia, 1968-83

OBSERVED,
'EXPECTED
Respiratory System
(160-163)

(95Z CI)

93

(63-134)

NS

110

(55-197)

NS

7

280

(113-577)

0.014

5

833

(271-1945)

0.0004

222

(62-579)

NS

500

(103-1461)

0.023

(12-118)

0.066

-

-

29,
'31.0

n
Digestive Organs and Peritoneum
(150-159)
Lymphoma
(200-203. 208-209)

to

Hodgklns Disease
(201)

POISSON p VALUE
(Fisher's exact)

sPMR

/
'10.0
'2.5

'.
06

U)

Male Genital Organs
(185-187)

*!.
/.

Cancer of the Testls
(186)

V
.

Malignant Melanoma of the Skin
(172)

VT

46

Soft and Connective Tissue
(171)

\

oo

Leukerolas
(204-207)

3

Oral Cavity
(140-149)

2
/

All Others

/1.9

2.4

8

/
'12.7

158

(33-461)

NS

83

(10-301)

NS

63

(27-124)

NS

�the skin also accounted for a significantly greater-than-expected
proportion

of

cancer

deaths

among

all

veterans,

but

the

contribution of in-country veterans to this excess was trivial in
comparison with that of era veterans.

Deaths from leukemias and

malignant neoplasms of the nervous system each occurred less
frequently than expected among both veteran groups.
tissue tumors,

For soft

a significant difference between observed and

expected deaths was not found for all veterans combined.

These

tumors occurred only among in-country veterans and not among era
veterans,

however.

When

in-country

veterans

alone

were

contrasted with nonveterans, they had a significantly elevated
standardized proportionate cancer mortality .ratio for soft tissue
tumors.

The

contrast between

in-country and era veteran cancer

deaths shows the difference in the observed (3) and expected (0)
soft

tissue

tumors

for

in-country

veterans

(Table

10).

In-country veterans also have significantly elevated standardized
proportionate
contrasted

cancer

with

era

mortality

ratios

veterans.

The

for

lymphoma

difference

is

when
more

specifically attributable to Hodgkin's disease, for which there
were five deaths in this group, compared with an expected 0.6.
Finally, there was a statistically significant excess in the sPMR
from testicular cancer among the in-country veterans.
Discussion
The present study demonstrates that the mortality experience

24

�among persons who served in the military during the Vietnam
Conflict differs substantially from that of nonveterans.

It also

suggests that there may be important differences between the
veterans who served in Vietnam and those who did not with respect
to their cancer mortality experience.

Differences in the mortality experience between veteran and
nonveteran groups are influenced by a selection bias initiated at
the time of induction to the military service.
assure

that healthy

individuals

In order to

serve in the military,

the

preinduction screening process excludes persons with preexisting
conditions

such

as

diabetes and

allergies, asthma, hypertension,

have

substantially

metabolic

disorders,

rheumatic heart disease, and

clinically apparent malignancies.
veterans

other

lower

Because of this selection,
mortality

rates

than the

nonveteran population for many years following their induction.
This is known as the "healthy veteran effect."

In the present

study, this selection bias is the most plausible hypothesis to
account for the significant sPMR deficits observed among veterans
for mortality from allergic, metabolic, and endocrine disorders,
all

other causes, rheumatic heart disease, and hypertension.

Moreover, it may also have contributed to the less prominently
diminished sPMRs among veterans for cardiovascular,

digestive,

and respiratory diseases.

While

real

differences

in the mortality

rates

between

veteran and nonveteran groups for selected causes are reflected

25

�in

the

sPMRs,

proportionate

they

also

mortality

complicate the
for

other

interpretation

causes.

Since

of
the

proportionate contribution from all separate causes must sum to
100, the proportionate contributions

among "healthy" veterans

from causes that are not screened by the induction process become
artificially inflated relative to their contribution among the
"unhealthy" population.

Injury, the leading cause of death for both veterans and
nonveterans, played a significantly greater role among veterans,
accounting for 58% of their deaths as opposed to an expected 51%.
Since the study did not adjust for discrepancies in the health
status between veterans and nonveterans, part of the excess in
injury among veterans must be due to the relative absence of
deaths from conditions that would exclude persons from military
service.

While an excess of these deaths araong nonveterans

reciprocally

diminishes

the

proportion

of

their mortality

attributable to injury, there may be a real difference in life
style

and

the

propensity

veterans and nonveterans.

for

risk-taking

behavior

between

An evaluation of injury mortality

alone, performed to eliminate distortion from the healthy veteran
bias, showed only that homicide was significantly less important
as

a

cause

nonveterans.

of

injury

death

among

veterans

than

On the other hand, while not significant,

among
the

difference between the observed and expected number of veteran
deaths from motor-vehicle accidents would suggest that this is at
least one area where veterans may be at a substantially greater

26

�risk

of death than nonveterans.

This

issue, however,

and

previous assertions that veterans are at greater risk of death
from suicide cannot be adequately addressed by this analysis in
the absence of more complete data on the populations at risk.

While

malignancies

as

a

group

accounted

for

similar

proportions of veteran and nonveteran deaths, deaths from tumors
of the respiratory system were a significantly more prominent
cause of cancer death among veterans than among nonveterans.
probable

explanation

for

this

finding

would

be

A

a greater

prevalence of smoking among military as compared with nonmilitary
personnel, but this cannot be substantiated from the limited
information available on death certificates.

In general, the pattern of death among in-country veterans
from all causes, and within the subcategories of "accidents,
poisoning, and violence" and "cardiovascular diseases," were
similar to those observed for all veterans combined, and there
were no substantial differences in the mortality patterns between
in-country and era veterans for these categories.

Among cancer

deaths, however, there was strong statistical evidence to suggest
that .Hodgkin's disease, cancer of the testis, and soft tissue
tumors were more common among veterans who served in Vietnam than
among veterans who did not.
cautiously,

however,

These findings must be interpreted

since

the

expected

proportions

of

site-specific cancer deaths for in-country veterans were derived
from a relatively small number (74) of cancer deaths among era
27

�veterans and would therefore be subject to considerably large
random fluctuations.

At the same time, the difference between

the observed and expected numbers of soft tissue tumors among
in-country

veterans

supports similar

proportionate mortality

findings

study conducted

in a previous

by the Massachusetts

Department of Public Health. Neither the Wisconsin study nor the
New York study found significant differences between in-country
and era veterans in the occurrence

of soft tissue

sarcomas.

These studies, however, and the present one are limited by the
absence of precise exposure data, unknown sizes of the candidate
populations at risk, and insufficient follow-up time to account
for

latency

from

in-country veterans.

exposures

that might have been unique to

Also, by including deaths from as early as

1968, the present study may have been biased against finding an
excess occurrence of cancers with long latency periods.

This study only suggests the possibility that the risk of
death

from

soft

tissue

sarcomas,

Hodgkin's

disease,

and

testicular cancer are elevated among veterans who served in
Vietnam.

We are currently awaiting the records of the in-country

veterans who died from these tumors in order to speculate about
possible exposure histories and to generate hypotheses that may
have some biologic plausibility.

To take advantage of latency

periods, cancer-specific proportionate mortality studies could be
repeated

in several years.

Also, by excluding

deaths

that

occurred in the late-Vietnam and early post-Vietnam period, and
by improving ascertainment of exposure histories, studies can

28

�focus more sharply on etiologic hypotheses relating to possible
exposures in Vietnam.

On the other hand, since proportionate

mortality studies are more useful to explore than to confirm
hypotheses, it is recommended that more precise risk-assessment
studies of Vietnam cohorts be performed using national data to
further test the hypothesis that Hodgkin's disease, testicular
malignancies, and soft tissue tumors may be important causes of
cancer mortality among veterans who served in Vietnam.

29

�BIBLIOGRAPHY

Dienstfrey, Stephen J., and James J. Bryne.
Veterans in the
United States; A Statistical Portrait from the 1980" Gensus.
Washington, D.C.: Veterans Administration, 1985.
"Final Toll for U.S. in Indb-China."
(Sept. 24, 1973): 73.

U.S. News £ World Report

Kogan, Michael D., and Clapp, Richard W. Mortality among Vietnam
Veterans in Mas sachuse t1s, 1972-1983. Boston: Massachusetts
Department of Public Health, 1985.
Lawrence, Charles E. et al. "Mortality Patterns of New York
State Vietnam Veterans." American Journal of Public Health
75 (March 1985): 277-79.
'
Shottenfeld, David, and Joseph F. Fraumeni, Jr., Cancer
Epidemiology and Prevention.
Philadelphia: W.B. Saunders
Company, 1982.

30

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24354">
              <text>069</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24355">
              <text>1868</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="24358">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24353">
                <text>Shepard, Barclay M.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24356">
                <text>February 4 1986</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24357">
                <text>Critique of West Virginia Mortality Study</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="24359">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
              <elementText elementTextId="24360">
                <text>mortality trends</text>
              </elementText>
              <elementText elementTextId="24361">
                <text>study criticism</text>
              </elementText>
              <elementText elementTextId="24362">
                <text>study protocol</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="2699" public="1" featured="0">
    <fileContainer>
      <file fileId="1486">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/4b6e0b217cdfbcc0568397aa68f8f4ce.pdf</src>
        <authentication>cdab8ab06c56a11d1a22a7ca0ad39b07</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63435">
                    <text>Item ID Number

01669

Author

Shepard, Barclay M.

Corporate Author
Report/Article Title Memorandum: Subject Amendments, from Barclay M.
Shepard to Director, Office of Procurement, March 5,
1984

Journal/Book Title
Year

000

°

Month/Day
Color

D

Number of Images

2

Desorlpton Notes

Wednesday, June 06, 2001

Page 1670 of 1688

�MAR 0 51984

Director r Aaent Orange 'Projects

Vl'J! ("?!} ?—-;J201&lt;!5, .•'s^jfkjsiii.'nfc
Niuwl^r 4 tan-* rrotxrisc1.! •I;^i-xi.-^;nfc

2. ^;jiri-?!sr&gt;nt ;iut?.S*?er 5 si'aowa, :&gt;c. Jos^j 5* Carra reuiacx^j Or. ?t
•:«. i^ut^ *» Project Otricer tor r&lt;SA «nd r^jujtc^s A^pircw.!;!! by th&lt;? -A*
4 L* K&gt;r*;aruQii tor vour intorwacion.
3. ?l*as« £eel £re« to contact carry &gt;toc^i*», 01^ ««t&lt;anf»ion 553*3, if
further I

ccs

Janet Ra«»iers, SPA
Dr. Hiohele Flicker, VRMC Kansas City, MO
Dr. Alvin Young
101611

�1 5 «*
Joseph 8. Carra, Ph.D,
Project Officer
Exposure Evaluation Division (TS-798)

Office of 'Ibxic Substances
Environmental Protection Agency
401 M Street, S.W.
Washington, D.C. 20460

Dear Dr. Carra:
Amendment nwaber five (5) to our interagency agreanent (V101 (91) P-82016)
was signed by the Veterans ^ministration's authorizing official on March
7, 1984. A signed copy is enclosed for your agency's records.
I am pleased that you are assuming the role of Project Officer for the
study. Dr. Han Rang is also looking forward to working with you.
-Sincerely,

BARCLAY M. SHEPAIO, M.D.

\

Director
Agent Orange Projects Office

']
r
!•'
*•

, /"•

Enclosure

. &gt;\

cc:
10A
101B11

Elaine
Jiit\ Jeffries, (91)

Dr. YoungX^
Dr. Michelle Flicker, VAMC Kansas City, ¥D

Dr. iSarnes,
Dr. Kutz, 2PA

SrrOCK?DS:jm

3/12/84

10A7B

10A7A

10A7

�Item ID Number

0167

Author

Flicker, Michele

°

Corporate Author
RODOrt/ArtlGlO TltlO

Letter: from

Michele Flicker to Alvin L. Young, January

4, 1985

Journal/Book Title
Yoar

000

°

Month/Day
Color

n

Number oflmaoes

5

DOSCriptOn NOtOS

Enclosures: a letter from F.D. Hileman providing results
from tissue samples he analyzed for TCDD and 2
newspaper articles discussing the study and Flicker's
involvement.

Wednesday, June 06, 2001

Page 1671 of 1688

�Veterans Administration

REFERENCE SLIP
TO (Name or title-Mail routing symbol)

INITIALS-DATE

jf

0 o
/I

2.

/V

3.

4.

5.

REASON FOR REFERENCE
L] AS REQUESTED

LJ FOR YOUR FILES

1_ 1 COMMENTS

I

(INFORMATION

[_J PER CONVERSATION

1_ 1 CONCURRENCE

I

(NECESSARY ACTION

I_ (SIGNATURE

wJLt&gt;

VA FORM
MAY 1980

(_ | NOTE AND RETURN

rt&amp;L'+--ty" k^J**^

EXISTING STOCKS OF VA FORM 3230,
AUG 1976, WILL BE USED.

* V.S. G.P.O. 1983-606-200

�Monsanto
MONSANTO COMPANY
Dayton Laboratory
1515 Nicholas Road
P.O. Box 8, Station B
Dayton, Ohio 45407
Phone:(513)268-3411
TWX 8 10-459- 1681

2 November 1984
Dr. Michele Flicker
Veterans Administration

Mail Code 11C
4801 Linwood Blvd.
Kansas City, Missouri

63167

Dear Michele:
I apologize for not writing sooner but it
cover from the trips taken in October. I
the TCDD data I had on three human tissue
the past year. The results, in parts per

has taken the past two weeks to rehave gone back and gathered together
samples that have been analyzed over
trillion, are shown below:

Tissue 2275519-1
November 1983
July 1984

1.7, 1.9, 2.0
2.1, 2.0

Tissue 2275519-7
June 1983
November 1983
July 1984

9.5
9.2, 8.6, 8.0
7.4, 7.2, 6.4

Tissue 2275519-8
November 1983
July 1984

10.6, 9.5, 6.3
6.5

In interpreting these results it should, be kept in mind that the results
generated in June and November of 1983 were done using a base digestion
technique and a 2,3,7,8-TCDD standard prepared in our laboratory. The
samples run in July 1984 were done using an acid digestion and a* 2,3,7,8-TCDD
standard provided by EPA. We are currently preparing to reanalyze these
tissues again using acid digestion and standards prepared in our laboratory.
This should provide information as to whether the lower results obtained
in July were the result of storage losses or due to the variability in the
analyses and analytical standards. When these analyses are complete, I will
write and inform you of the results.
It was pleasant to have a chance to meet you again in Canada and if I can be
of any further assistance, please feel free to contact me.
Sincerely,

F. D. Hileman

�KC doctor

Kansas City researcher is
seeking final federal approval for a study to deterT\yhether,,more,dfoxin Js ,
iund fo|he fat tissue of Vietnam
sterans! t i in*• other-a.Amerithan
r.i' •:,
»••
.:..
%-,.*' W-- •:• '• •-*.•,.' •--.,

Flicker and a reat t^e Midwest Reate want to find out
exposed to
Orange herbicide

of the toxic chemithan the general population.
Agent Orange was used exteniant. '"''•''*••"-j 7:.:&gt;S''f;r •'"
. flicker's" research, ap" by the Veterans Adminisn, could play a role in
ddressing concerns of
of Vietnam veterans
blame dioxin for health
Problems in themselves and
t teir children^ including skin dis4ases, cancers and birth defects.
It also would help future dioxin
Agent Orange research by
normal back-;
dioxin in U.S.- :
,isaid..S";:'v:v
. Flicker alsp is a staff phyat Veterans Hospital in
s City and principal naco^nvestigator with the.,
ed Veterans AdmlnistraOrange Project.
- *r study would look at only
most toxic of the family of
ixins, the type found in Agent
ge and at Missouri sites
minated by waste off con- •
ln£ the substance. ,.
{'
nus is the one study that will
at any differences in dioxin
vels in veterans and noivVeter' Dr. flicker said. It would"
ve staff of the Veterans Adtration and the Environntal t*rotectioja "Agency and
Bike use *of 1J laboratories
nation, including the

�-V
archers would use
in 21,000 preserved sanv
AV-v-vr&gt;
1,000 samples, she said,
are from people born
'1937 and 1955. Statistibut 30 to 60 are expected

'Xin have been found in fly ash,
arette smoke, charcoaled
and, automobile exhaust,
JSirice 1946 the most toxic dfoxIB has been a* byproduct and ofa contaminant of trichloroa chemical formerly
in some cleansers and still
ujted in some industrial
processes. Trichlorophenol is an
ingredient of Agent Orange.
•Science still has not deternSined how dangerous dioxin is to
'** humans. The toxin earned its
reputation as the most lethal /
njan-made ^chemical because a
minute quantity will kill a guinea
pig. Its effects on different species vary greatly, however, and
hiimans appear to be among the
njost dioxin-resistant animals.
«Dr. Flicker noted that no resf arch^bas tied skin cancer or
circulatory problems to dioxin,
although an Air Force study of
liffiOO fliers who sprayed Agent
Orange in Vietnam ' showed
higher r-ates of skin cancer and
circulatory problems. The
h|gher incidence could be caused
because the men got greater exposure to the sun and because
many of the men smoked cigarettes, she said.
! Hie probabilities are stacking
u &gt; that many veteran health
problems are not associated with .
dioxin, Dr. Flicker said.
Veterans and seven chemical
companies that produced Agent
Orange reached an out-of-court,
1^0 million settlement earlier
this year, with the money
eventually to go to veterans who
have suffered proven health
VSi damage from exposure to the
hfrbicide.
,.-, ;~ ,4. , b

•••:

\-teiS fyd seamy

••*«#-•• x*

�If***

Vietnam lessons fad
ns from the audience on videotape.
Fall's letter showed that historians and ar* member erf the editorial staff
„, Ists can confront the recent past and try to do it
he dear colleague letter from the History De- well. Where they may fail in the eyes of some is in
partment chairman stated the problem suc- not showing the connections between recent histocinctly: "It has come as something of a ry 'and modern events — almost always
shock to many of us to discover we are now teach- guaranteed to engender controversy. The Vietnam
ing students to whom the Vietnam War and the series could have used that touch.
,• social Upheaval of that era is no more than a re- Questions to the panelists and my own conversa-, *note childhood memory."
tions with members of the audience, who ranged
Surprising?
from high school children on assignment to grandi
Yes, and no. College freshmen
parents, showed how much interest, curiosity and
today were about'7 years old
raw feelings hang on from Vietnam. One woman,
,' «when the last regular American
•concerned about Hie growing U.S. involvement in
-•troops pulled out of Vietnam. The war in Indochina Central America, stood to ask former Rep. Rich.-that shaped a generation and poisoned a nation's ard Boiling what the United States has learned
spirit has all the relevance of the Peloponnesian from Vietnam that can be applied to the present
; War for many of today's students planning their and the future. Mr. Boiling replied that a president
v
:'. careers.
- , •
'
' ; • ' • • ' -•'"•' '•&lt;"* "'cannot delegate responsibility for making war and
- But the national experience in Southeast Asia, peace. He added that Americans have little pathe politicizatton of foreign policy, doubts and bra- tience for long wars with no clear victory." '
vado over armed intervention, the battle to stem
Suzann Settle, a Southwest High School teacher,
inflation and deep concern over Agent Orange and .assigned the series to her students for extra credit.
environmental degradation share a common "I see Vietnam as a trick bag," Ms. Settle said. "I
source in the Vietnam era. Certainly the politics of believe we got tricked into it by our leaders....
the anti-war protest movement has its offspring in We're studying the American Revolutionary War,
. t h e nuclear freeze movement and growing demon- which was not unlike Vietnam for the Vietnamese.
strations against U.S.-supported military action The parallels are pretty handy right now. If we
^against Nicaragua and in Central America.
have war in Central America...."
Connections abound. Vietnam is relevant. One . The series of panel discussions on Vietnam over
has only to be shown, as the recent panel discus- seven weeks (Oct. 2 through Nov. 13) brought
sions at the University of Missouri-Kansas City on together former enemies—and no Viet Cong was on
the Vietnam War attempted for the several hun- the panel. An active duty Army lieutenant colonel
dred persons who attended.
with two combat tours and a former enlisted man
In his letter, Professor James Falls of UMKC who organized draft resistance when he returned
Was calling attention to the latest in a series of from Vietnam sat at opposite ends of the panel
annual panel discussions co-sponsored by the His- table the night I participated. The distance
\ tory Department and the Kansas City branch of the between them was more than the several meters
National Archives, the federal agency that keeps from one to the other. At one point, the Army offirecords on many aspects of the American people cer said he would not have been present with the
former enlisted man a year earlier. His feelings of
and their experiences.
The series have shown documentary, commer- resentment to the protest movement were obvious.
In another session, the present controversy over
.. cial and government movies—some have been real
jewels—and had discussions on World Wars I and possible effects on veterans and their offspring of
II, the Korean War, the Great Depression, govern- Agent Orange, a defoliant used by the U.S. Air
ment propaganda and presidential politics. Viet- Force to rid the tropical jungle of its foliage, flared
nam was the freshest in terms of a national into the open. Dr. Micheie Flicker, a staff physi- r
cian at the Veterans Medical Center here, had the!
experience.
"It isn't possible to put this into perspective," thankless task—for which she volunteered—of exsaid Alan Perry, the archivist who helped organize plaining repeatedly that no proof exists that Agent
.the series. "But we have to deal with current Orange causes birth defects in veterans' children
.
events, even if we don't have everything. The poli- or cancer in veterans.
Dr. Flicker was not believed, perhaps because
cy questions raised by Vietnam still are very much
with us. For instance, the phrase, 'No more Mun- some veterans need a scapegoat for their troubles
ichs' (from the appeasement of Hitler before since Vietnam. Agent Orange and the Veterans AdWorld War II), was one of the rationales used to ministration may fill that role well.
And so it went, from the buildup in the mid 1960s
buttress the arguments to get into Vietnam."
There is something very commendable about to the use of technology to fight a guerrilla enemy
this outreach effort by the archives (which con- to the massive student protests in the streets at
jures images of musty, handwritten documents) home.
If a cardinal frustration remained from the seand the local university. In fact, Mr. Perry believes this is the only effort of its kind outside of ries, it was that there wasn't more time, more of
Washington. Hours and hours were spent by Mr. the public attending, more controversial panelists
Perry and Mr. Falls and others to sort through and more attention to what Vietnam means in
film, TV ncwsreels and locate qualified panelists to terms of foreign policy, relations with Third World
discuss these pivotal events in modern U.S. histo- nations in transition, fighting wars of indefinite
ry. For the price of time only, a member of the conclusions and effects on veterans and their famipublic could gain valuable impressions and infor- lies.
mation about a war Iik6 Vietnam or World War II.
Mr. Perry would like to do Vietnam again in two
years and hopes to preserve the discussion and

•"'By Repps Hudson

T

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="19113">
              <text>061</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="19114">
              <text>1669</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="19116">
              <text>Series III Subseries III</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="19112">
                <text>Shepard, Barclay M.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="19115">
                <text>Memorandum: Subject Amendments, from Barclay M. Shepard to Director, Office of Procurement, March 5, 1984</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="19117">
                <text>VA/EPA TCDD Assay</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="2534" public="1" featured="0">
    <fileContainer>
      <file fileId="1366">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/e60d6e0915a2c041b9cb88f357f1c009.pdf</src>
        <authentication>c26923e4beba70ccf43ac8c3d4b04e26</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63315">
                    <text>Item ID Number

01496

Author

Shepard, B. M.

Corporate Author
Roport/Arttehj TltlO Typescript: Chapter 6: The Risk of Soft Tissue
Sarcoma in Veterans of the Vietnam Conflict

Journal/Book Title
°00°

Year
Month/Day
Color

n

Numberoflmae.es

25

DOSCriptOD NOtflS

This manuscript is a draft version of a chapter or section
from the following book: Agent Orange and its
Associated Dioxin: Assessment of a Controversy,
Young, A. L. and G. M. Reggiani, eds. New York:
Elsevier, 1988. This book is available in the NAL
collection, call no.: RA1242 T44 A3.

Tuesday, May 15, 2001

Page 1496 of 1514

�CHAPTER 6
"Perhaps the greatest fear held by veterans of the Vietnam
conflict was the fear of Cancer because they had been exposed to
Agent Orange"
THE RISK OF SOFT TISSUE SARCOMA IN VETERANS
OF THE VIETNAM CONFLICT
B.M. Shepard, H.K. Rang, F.M. Enzinger, L.B. Hobson

Ever since the reports by Hardell and Sandstrom (1979) ,
Eriksson et al. (1981) and others began to appear in Sweden
in the late 1970's, the concern that exposure to the phenoxy
acid herbicides increases the risk of developing one of ,.the
soft tissue cancers has persisted in the minds of scientists
and non-scientists alike.

This concern coincided with the

growing fear among many veterans of the Vietnam conflict that
service in that country and especially exposure to the
phenoxy herbicides used for strategic purposes during that
military action posed a major risk for developing a wide
variety of serious health problems.

It was inevitable,

therefore, that soft tissue sarcomas quickly joined the
growing list of adverse health effects attributed to exposure
to the phenoxj? -herbicides used in Vietnam.

By far the

predominant Herbicide used was code named Agency Orange.

It

was a 50:50 mixture of 2,4-D and 2,4,5-T, the latter
containing trace amounts of 2,3,7,,8-TCDD ranging between 1
and 47 parts-per-million (ppm).

The average concentration

was estimated to be approximately 2 ppm.

The distinction

�between the active herbicidal ingredients and the dioxin
contaminant as being the "causative" agent of these various
health problems including the soft tissue sarcomas has
remained clouded, although there is little evidence to
implicate 2,4-D or 2,4,5-T alone as human carcinogens.
The reports of. Hardell and his associates linking phenoxy
herbicide exposure with soft tissue sarcomas and related
concerns among Vietnam veterans have stimulated a series of
studies in the United States designed to shed more light on
this perplexing and troublesome issue.

Meanwhile the

concerns of Vietnam veterans in this area drew considerable
attention in the U.S. Congress where the issue was
heatedly debated and became the subject of a number of
legislative initiatives designed to mandate additional
research in this area as well as to provide compensation and
special medical care eligibility for Vietnam veterans who
developed one of these rare types of cancer.
This chapter will provide an overview of what is known
generally about this group of tumors and will summarize the
results of some of the studies designed to determine if
service in "'y
Vietnam and herbicide exposure have increased the
'
5,

risk for developing soft tissue sarcomas.
"V

INCIDENCE, DEFINITION AND DISTRIBUTION
Soft tissue sarcomas, compared to carcinomas and other
neoplasms are relatively rare tumors.

It is estimated that

�they account for about 1% of all cancers and are responsible
for about 2% of all cancer deaths.

Between 5000 and 7500 new

cases are diagnosed each year in the United States.

It has

been suggested that there is an upward trend in the incidence
of soft tissue sarcomas, but it is not clear whether this
represents a true increase or whether it reflects merely
better diagnostic capabilities and greater interest in this
type of tumor.

The average annual age-adjusted incidence

rate is 2.0 to 3.5 per 100,000 population, but the rate
varies not only in different age groups, but also depends
upon the definition of soft tissue sarcomas and the types of
neoplasms that are included among these tumors.

For example,

in the National Cancer Survey, retroperitoneal, mesenteric
and omental sarcomas are counted among the neoplasms of the
digestive system and pleural sarcomas (malignant mesotheliomas) are included among the tumors of the respiratory
system.

Judging from the available data, incidence and

distribution of soft tissue sarcomas seem to be similar in
different geographic regions of the world (Tucker and
Franmeni, 1982).
As the name indicates soft tissue sarcomas are usually
*'"''
defined as extra-skeletal, non-epithelial sarcomas that arise
chie.fXy in musple, fat or fibrous connective tissue such as
tendons or ligaments and less frequently in blood vessels and
nerves that serve these tissues. Consequently, soft tissue
sarcomas may occur anywhere in the body, but the majority

�originate in the large muscles of the extremities, the chest
wall, mediastinum and retroperitoneum.

Excluded are sarcomas

of the brain and other major organs, such as the heart,
lungs, kidneys, liver and intestinal tract.

Excluded also

are the tumors of the hematopoietic system, such as leukemias
as well as malignant lymphomas and Hodgkin's disease
(Enzinger et al. 1969; Enzinger and Weiss, 1983).
Soft tissue sarcomas may occur at any age: about 15% affect
persons younger than 15 years old and about 35% occur in
persons 55 years or older.

In general they are somewhat more

common in males than in females.

The age and sex incidence,

however, varies among different histologic types.

There is

no proven racial variation, even though the annual age-

:

adjusted incidence rates have been reported in some cases to
be higher for blacks than whites.

CATION AND DIAGNOSIS
On clinical examination, as well as direct visualization and
palpation during surgery, soft tissue sarcomas as a group
tend to display a fairly uniform picture.

When examined

under the microscope, however, they vary greatly in
appearance and actually comprise an extremely varied and
highly complex group of neoplasms rather than a single
entity.

At present, the classification recognizes 25 major

types of soft tissue sarcoma, many of which can be further
divided into one or more subtypes on the basis of their

4

�histologic characteristics.
Classification and diagnosis by subtypes are essential
because the clinical behavior and response to therapy
frequently depend not only upon the histogenetic type but
also upon the degree of cellular differentiation or grade of
the tumor.

The various types are named according to the

predominant cellular elements and the resemblance of the
tumor to normal tissue or its embryonal counterpart.
Malignant fibrous histiocytoma, liposarcoma and fibrosarcoma
are the most common soft tissue sarcomas of adult life;
together they account for more than 50% of all cases.
Rhabdomyosarcoma, neuroblastoma and extra-skeletal Swings
sarcoma are the most frequent types of soft tissue sarcoma in
children.
Correct diagnosis of these tumors is still largely dependent
on incisional or excisional biopsy in order to provide the
pathologist with a specimen of sufficient size for an
accurate description and identification.

In recent years

percutaneuous needed biopsy and aspiration have become
increasingly popular as a means of diagnosing many types of
neoplasms.

Reliance on these techniques when dealing with

this group of tumors, however, should be approached with
great caution, since they provide only a minute specimen which
may not be representative of the entire tumor.

But even with

adequate material many soft tissue sarcomas present a
diagnostic dilemma, and an accurate diagnosis often requires

�examination with the transmission or scanning electron
microscope.
techniques

More recently the use of immunohistochemical
in the study of soft tissue sarcomas has

profoundly changed the approach to the diagnosis of these
tumors and has permitted an accuracy of diagnosis unheard of
only a few years ago.

BEHAVIOR AND THERAPY
The various types of soft tissue sarcoma differ considerably
in their degree of malignancy, and identification and
diagnosis of the exact histologic type and subtype are
essential for predicting the clinical course of the tumor as
well as selecting the best method and plan for treatment
(Costa et al. 1984; Mandard et al. 1981).

Despite a wide

variety of therapeutic modalities, it is generally agreed
that surgical resection, when possible, is still the
treatment of choice for primary soft tissue sarcomas.
Chemotherapy and radiotherapy serve as adjunctive forms of
treatment, especially in highly malignant sarcomas.

When

planning definitive surgery, it is important to know as much
as possible about the extent of the lesion as well as the
&gt;• •'•

type and grade of the tumor.

Since the extent of the tumor

is not always evident microscopically, it is most important
that the margins of the resection be checked by the pathologist during the operative procedure.

The best chance of cure

is achieved with total excision during the initial surgical

�procedure.

Since many sarcomas develop microscopic met-

astases early in the course of the disease, the ultimate
outcome of these tumors must be assessed with considerable
caution and long term follow-up is essential, especially in
the case of high grade soft tissue sarcomas.

The outcome is

much less favorable with recurrent tumors and with large
unresectable tumors such as many sarcomas in the retroperitoneum (Eilber et al, 1984; Enneking, 1983; Rosenberg,

1982) .
Soft tissue sarcomas occurring in childhood often respond
extremely well to combination therapy with some reported cure
rates as high as 80%.

For this reason surgery in this age

group can usually be less radical when combined with

•-

radiation and chemotherapy.

PATHOGENESIS
As with other types of malignant neoplasms, the causative
factors of soft tissue sarcomas, are still for the most part
unknown. The development of sarcomas from benign soft tissue
tumors is rare.

A notable exception to this rule is the

appearaftce pf malignant neural tumors arising in
neurof ibromas... .In this instance it is nearly always seen in
T
patients with previously determined manifestations of
neurofibromas. A few causative agents and predisposing
factors have been clearly established and include various
physical and chemical exposures such as ionizing radiation

�and asbestos as well as various inherited or acquired
immunologic defects.

Determination of the exact cause is

often extremely difficult, because of the long latent period
between the time of exposure and appearance of the sarcoma.
The possible effect of multiple environmental and hereditary
factors during the induction period further complicates any
attempt to establish the causative agent or other
circumstances (Enzinger and Weiss, 1983).
Considering the extensive use of radiotherapy, radiation
induced sarcomas are extremely rare and therefore the benefit
of radiation in the treatment of malignant neoplasms, far
outweighs the risk of developing such a sarcoma.

It has been

estimated that only about 1% of patients who survive 5 years
following intensive radiation therapy for breast carcinoma,
malignant lymphoma or other types of malignant neoplasm,
develop a soft tissue sarcoma in the area of radiotherapy.
Almost any type of soft tissue sarcoma may arise following
radiation, but the two most common types are malignant
fibrous histiocytoma and extra-skeletal osteosarcoma.

There

is a close relationship between the total radiation dosage
and the risk' of developing a sarcoma (Halperin, et al, 1984;
Kim, 1978).
In addition to radiation, immunodeficiency and therapeutic
immunosuppression are known to be associated with the
development of soft tissue sarcomas.

For example virus-

induced immunodeficiency such as in the case of acquired

8

�immune deficiency syndrome (AIDS) has been recognized as
causing Kaposi's sarcoma in almost 1/3 of the affected
patients. The profound depression of cell-mediated immunity
in these patients is the result of a defect in the T-4
inducer or helper subset of T-lymphocytes.

Kaposi's sarcoma

carries a high mortality rate with a median survival of 18 to
20 months.
Aside from their role in the development of Kaposi's sarcoma,
there is no evidence that human transmissible viral agents
constitute a major risk factor in the development of soft
tissue sarcomas.

However, using the electron microscope,

particulate material, which may represent viral fragments,;
has been found repeatedly in soft tissue sarcomas.

The

origin and significance of this material, however, have not
yet been conclusively established.
Various types of sarcomas also occur secondary to therapeutic
immunosuppression associated with organ transplantation,
especially in renal transplant recipients.

Acquired immune

deficiency may also be the underlying mechanism in the
development of the relatively rare angiosarcomas or
lymphangiosarcomas that arise in the edematous extremity,
•M ,
'

either secondary to radical mastectomy (Stewart-Treves
Syndrome) or as a consequence of other forms of chronic
lymphedema.
There are only a few environmental factors that are
associated with the development of soft tissue sarcomas.

�About 80% of patients with pleural or peritoneal mesothelioma
give a history of asbestos exposure, usually 25 years or more
prior to the first appearance of this tumor.

As increased

incidence is found in asbestos miners as well as shipyard and
other industrial workers engaged in the process of
manufacturing, installing or repairing asbestos containing
products such as thermal and electrical insulation, brake
linings and cement tiles and pipes.

Important risk factors

include the intensity and duration of asbestos exposure as
well as the type and submicroscopic diameter of the asbestos
fiber (Selikoff et al 1964; Selikoff and Hammond, 1979).
Soft tissue sarcomas have also been reported as arising in
scar tissue following surgical procedures or thermal burns,
in fracture sites and rarely in the vicinity of plastic or
metal implants.

Whether trauma per se ever leads to a

sarcoma has not been clearly established, but in most
instances the association with mechanical trauma appears to
be coincidental rather than causative.

EPIDEMIOLOGICAL TECHNIQUES USED TO STUDY THE SOFT TISSUE SARCOMA ISSI
Research efforts designed and conducted to shed more light on
•

&lt; •'

^ * ^*St&gt;%,

• the relationship between adverse health effects in humans and
'exposure to the phenoxy herbicides and trace amounts of the
'•A '•
dioxin contaminant found in 2,4,5-T have usually been in one
of two general categories or types of epidemiological study
design.

These are case/control studies and cohort studies.
10

�Each of these types has its own strengths and weaknesses, but
when taken in combination they can provide a convincing body
of evidence.

The case/control design is well suited for the

study of rare events such as soft tissue sarcomas. Two
features of such a study, however, are of paramount
importance:

accurate diagnosis of the disease in question

and assurance of non-bias in the selection of the controls.
The cohort study is probably the most widely used method to
determine the relationship between exposure to a particular
chemical or other environmental factor (s) and a disease or
group of diseases.

Using this study design, however, the

rarer the outcome being studied, the larger the cohort,.must
be.

In this type of study the accuracy of exposure data for

each member of the cohort of interest is of key importance.
Again, the selection of the comparison or control cohort must
be carried out with great care.
The mortality experience of a group can be used to look for
possible cause-and-effeet relationships between an exposure
of concern and adverse health outcomes.

The two commonly

used analytical techniques are known as the proportionate
m r a i y * ' ! ' (PMR) and the standardized mortality ratio
otlt^*!?
i.
"•
• ,-,*&gt;:'/•?*
'^'
(SMR) . In general, when using the SMR one determines and
r'tiSj "^. .'
-

-Jf
•"»!* ** "

compares the numbers and causes of death in a particular
study group and a comparison group.

This method has the

potential for and the advantage of providing death rates if
sufficiently large cohorts are used.
11

As with the cohort

�morbidity study, the rarer the outcome, the larger the cohort
must be.

The PMR on the other hand cannot generally provide

death rates, but can provide relative frequencies by cause of
death.

These relative frequencies in the group of interest,

as for example a group of deceased Vietnam veterans, can be
compared to those in a comparison group, i.e., veterans of
the same age and sex who served elsewhere.

In addition the

frequencies may be compared to those known to exist for age
and sex specific segments of the general population.

In the

case of veterans, however, the latter method of comparison is
generally considered less valid since veterans represent a
highly selected group of individuals and their patterns of
death, especially in the first half of life are somewhat

,-

different from those seen in the general civilian population.

12

�REVIEW OF STUDIES OF SOFT TISSUE SARCOMAS
IN VIETNAM VETERANS

VETERANS ADMINISTRATION STUDY
In view of the concern raised by this issue among Vietnam
veterans, a case comparison group analysis of patients
treated in Veterans Administration hospitals was undertaken
to determine the association between previous military
service in Vietnam and soft tissue sarcomas (Rang et al.
1986).

A total of 418 cases with International

Classification of Disease

(ICD) 171 diagnosis, i.e.,

malignant neoplasms of connective and other soft tissues,;;
were identified by computer search of the Veterans

...

Administration Patient Treatment File (PTF) for Vietnam era
veterans who were hospitalized between 1969 and 1983.

The

PTF is a large computerized hospital data base of in-patient
records which includes diagnostic and demographic
information.

A pathology report for each of theses 418 cases

was requested from the appropriate VA hospital and a total of
394 pathology reports were received.
reports were reviewed by a single VA
pathologist With particular expertise in this area of cancer
diagnosis.

He;had no knowledge of the Vietnam service status

of any of the cases.

A total of 234 of these cases were

determined to meet the World Health Organization (WHO)
classification system for soft tissue sarcoma.

13

The

�comparison group consisted of 14,931 VA hospital patients who
were systematically sampled from the same Vietnam era veteran
patient population from which the cases were identified.
Military service information, in particular the Vietnam
service status, for each STS case and control patient was
obtained from a comprehensive review of the military
personnel records at the National Personnel Records Center
(NPRC) in St. Louis Missouri.

Military personnel records

were located and abstracted for all of the 234 STS cases and
13,496 of the 14,931 (90%) control patients.
V

Eighty six of the 234 STS cases (36.8%) had served in Vietnam.
':- 5# .

whereas of the sample of 13,496 Vietnam era patients who's^t
''."*• * f
personnel records were located and reviewed, 5544 (41%) had
served in Vietnam.

On the basis of this comparison it was

concluded that no significant association of soft tissue
sarcomas and previous military service in Vietnam exists
among Vietnam era veterans who come to the VA hospital for
inpatient medical care.

The odds ratio was 0.83 with a 95%

confidence interval of 0.63-1.09.
In order to further strengthen the study, the tissue slides
• '•; -iS1

from/all the&lt;?a$es originally coded as ICD 171 in the PTF
•«' if,
were requested^$rom the VA Medical Centers. The tissue
specimens f.0r 1 8 cases were located and sent to Dr. Franz
'1
Enzinger at the Armed Forces Institute of Pathology for his
review.

During the review, Dr.Enzinger knew neither the

Vietnam service status of the cases nor the VA's diagnoses.
14

�Following his review a comparison was made between his
diagnosis and that of the VA Pathologist who had reviewed the
pathology reports.

Among the 181 cases he reviewed, he

concurred with the VA diagnosis in 171 cases (94.5%):
cases, STS; 73 cases, non-STS.

98

However, for 10 cases he

disagreed with the VA's diagnosis:

4 cases that VA

classified as non-STS, he classified as STS; 6 cases that VA
determined as STS, he reclassified as non-STS.

Military

service information was available for 96 of the 98 ICD 171
cases that both VA and AFIP agreed to be STS cases.

A record

of Vietnam service was indicated on 33 of the 96 STS cases
(34.4%).
Comparing this proportion to the proportion of Vietnam
veterans in the comparison group, no significant association
of soft tissue sarcoma and previous military service in
Vietnam was observed. (The odds ratio was 0.75 with a 95%
confidence interval of 0.49-1.15.)

U.S. Air Force Health Study
A group of approximately 1260 men who conducted the Ranch
Hand fixed wing, aerial herbicide spraying missions in Vietnam
from 1962 through 1971 is being studied for their mortality
patterns and the current health status.

Cumulative mortality

as of December 31, 1984, in Ranch Hand personnel revealed no
death from soft tissue sarcoma (Wolf et al., 1985).

Although

the study did not indicate any increased mortality or any
15

�unusual patterns of death, it should not be regarded as final
because of the small number of study subjects and the
relatively short follow-up period.

STATE STUDIES OF SOFT TISSUE SARCOMA IN VIETNAM VETERANS
In four states-New York, Massachusetts, West Virginia, and
Wisconsin-investigators have conducted mortality studies that
include soft-tiss.ue sarcomas among the causes of death.

In

each study there have been relatively few cases of soft
tissue sarcoma and the results in this area have not been
: £

consistent.

In addition to the mortality studies, a case

control study of soft tissue sarcoma was conducted in New
York.

New York
Greenwald et al. (1984) conducted a case-control study in
which he identified 281 soft-tissue sarcoma cases in the New
York State Cancer Registry among men who were between the
ages of 18 and 29 during the period 1962-1971 and who were
diagnosed between 1962 and 1980.
y

At the time of the study,

. '•*

151 of the 281 cases were still alive and 130 had died.
Using the'driver's license registration files of the N.Y.
State Department of Motor Vehicles, a living male control was
selected to match each of the 281 cases by being within 5years of the birth date and within the same ZIP code of

16

�residence.

In addition, a deceased control was selected for

each of the deceased cases.

The deceased cases and the

deceased controls were also matched for race, sex, the year
of death, 5-year age group, year of education and health
system area.

Of 281 cases, 10 men had served in Vietnam as

had 18 men of 281 living controls and 9 of 129 deceased
controls.

This carefully conducted case-control study

demonstrates "no statistically significant positive
association between sarcomas of soft-tissues and either
service in Vietnam or military service in general."
Lawrence et al. (1985) undertook a mortality study involving
1,496 male Vietnam-era veterans of whom 555 or 37% served.:
'
I
Vietnam and all of whom died in New York State (but outsid£
New York City) during 1965-1967 or 1970-80.

Among the 555

Vietnam veterans, 2 died of cancer of connective and soft
tissues and 3 of the 941 non-Vietnam veterans died from this
same category of cancer.

This resulted in an adjusted

mortality odds ratio (MOR) for connective and soft-tissue
cancers of 1.09; 95% CI of 0.18 - 6.70.

In addition, the

study included a comparison of mortality patterns between
4558 deceased v&amp;terans of the Vietnam era and 17,936 nonveteran males of the same age group who had died in New York
State.

There were 12 connective and soft tissue cancers

among the veterans and 47 among the non-veterans
95% CI 0.61 - 2.17).

These

(MOR=1.15:

data suggest that there was no

significant difference in deaths due to soft tissue sarcomas
17

�between Vietnam veterans and non-Vietnam veterans as well as
between veterans and non-veterans.

The small number of

cases, however, make the results relating to soft tissue
sarcoma of limited value.

Massachusetts
Kogan and Clapp (1985) in the report of a mortality study
conducted in Massachusetts described their results as showing
"a statistically highly significant excess of soft tissue
sarcoma mortality in Massachusetts Vietnam veterans."

The

two veteran groups, those with service in Vietnam and those
who served elsewhere were identified from a list of honorably
discharged service men who applied for a state bonus and whose names appeared in the Massachusetts death registry.
Vietnam service status was determined from the fact that in
granting the bonus a larger amount was paid to those who
served in Vietnam.

The cause of death was obtained from

death certificates.

No verification of military service

beyond the discharge certificate (DD214) was attempted.
Among the 840 deceased Vietnam veterans nine deaths were
believed tf&amp;JtyidLdue to soft tissue sarcoma.

Statistical

calculations found that 1.02 deaths from connective and softtissue cancerrwould have been expected among Vietnam-era
veterans and 1.90 deaths among non-veterans.

Such

differences are striking.
The validity of the Massachusetts study is somewhat in
18

�question however, because verification of Vietnam service
status was not attempted.

The DD214 often does not show the

specific place of service as Vietnam. In addition when dealing with such relatively rare causes of death as soft tissue
sarcoma where the diagnosis can be difficult to make it is
generally agreed that verification of the diagnosis by a
pathologist with expertise in this area is necessary in order
to draw valid conclusions regarding this type of cancer.
West Virginia
The fact that reliance on the DD214 to determine service in
Vietnam may be misleading is illustrated in a mortality study
of West Virginia veterans conducted by Holmes, et al. (1986).
The study groups were compiled from a list of 83,730 bonusfe
applicants of whom 41,059 qualified as Vietnam veterans and
41,782 as non-Vietnam veterans.

The DD214 was used to

determine whether or not the veteran had served in Vietnam
and the cause of death was obtained from death certificates.
Comparison of the bonus roster with the death register
revealed that 615 Vietnam and 610 non-Vietnam male veterans
had died.

Among these were 3 deaths attributed to soft-

tissue sarcoma.;5 and all were among veterans classified as
having served in Vietnam.

No soft tissue sarcoma deaths were

found among the non-Vietnam veterans.
Subsequent to publishing the report, the military service
records of the three veterans who died of soft-tissue sarcoma
were examined.

One veteran was in the Navy and had served
19

�aboard ship off the coast of Vietnam, a second was stationed
in Thailand, and the third served with an Army combat unit in
Vietnam.

Thus, only one soft-tissue sarcoma death occurred

in a Vietnam veteran with actual in-country service.

Wisconsin
Anderson et al. (1986) issued a report of a study of
Wisconsin veterans in which Vietnam service status was
determined from the DD214 and the cause of death from the
death certificate.

Two epidemiological techniques were used:

"proportionate mortality ratio" (PMR) comparing the relative
number of deaths from that cause expected on the basis of
experience in another, e.g., Vietnam-era veterans, or

.,

"standardized mortality ratio" (SMR) comparing the causespecific death rates in the two groups.
A comparison of the proportion of STS deaths in 923 deceased
Vietnam veterans with the same proportion in 1,571 deceased
non-Vietnam veterans showed no statistically significant
increase in the proportion of soft-tissue sarcoma (PMR, 147;
95% CI, 62-350).

There were, however, only 5 deaths

tabulated £ra»J8oft-tissue sarcoma among Vietnam veterans and
the tabulated information about these cases indicated that
one&gt;man;had a,"wide-spread carcinoma", apparently
misclassified as a soft-tissue sarcoma.

This reduces to 4

the number of soft-tissue sarcoma deaths and further
diminishes the significance of any differences.
20

�An SMR analysis comparing the deaths among Vietnam veterans
with the deaths among Wisconsin, non Vietnam veterans, was
based on 4 STS deaths among 43,398 Vietnam veterans and 5 STS
deaths among 78,840 non Vietnam veterans.

Both groups had

less risk of dying from soft-tissue sarcoma when compared to
the entire state of Wisconsin.

Vietnam veterans had a

somewhat greater risk than non Vietnam veterans but the
observed elevation was not statistically significant.
Discussion
The absence of a consistently positive association between
soft tissue sarcoma and Vietnam service might be a result of
insufficient observation time since Agent Orange exposure in
Vietnam.

In general, it takes more than a decade for cancer

to manifest itself if it is induced by a chemical carcinogen.
Another possibility it that even if Agent Orange or dioxin
has the potential for including STS in humans, Vietnam
veterans as a group, were exposed to such small amounts that
the conventional epidemiologic study cannot detect the excess
risk resulting from Agent Orange exposure in Vietnam.
Alternatively, there is the possibility that neither Agent
Orange nor clioxin has the potential for inducing STS in
humans.
In conclusion, studies of STS in Vietnam veterans, in
general,have not revealed a statistically significant
positive association between STS and previous military
service in Vietnam.
21

�SUMMARY OF SOFT TISSUE SARCOMA STUDIES OF
VIETNAM VETERANS
AUTHORS

STUDY DESIGN

STUDY POPULATION

Greenwald, et al
(1984)

Case/Control

281 STS cases, 18-29 years
old anytime between
1962-1971 in NY State
Cancer Registry

Odds ratio = 0.53
(95% CI 0.21-1.31)

Lawrence, et al.
(1985)

PMR

555 NY State Vietnam
veteran deaths between
1965 and 1980, exclusive
1968 and 1969

Vietnam: 2 STS/555 deaths
Non Vietnam: 3 STS/941
deaths, Mortality odds
ratio= 1.09 (95% CI
0.18-6.70)

Kogan &amp; Clapp
(1985)

PMR

840 Massachusetts State
Vietnam veteran deaths

9 STS deaths vs. 1.02
expected, PMR=880 (P&lt;0.0001)

Anderson, et al
(1986)

PMR

923 Wisconsin State
Vietnam veterans deaths

5 STS death vs. 3.40
expected, PMR= 147
(95% CI 62-350)

SMR

43,398 Wisconsin State
Vietnam veterans, of which
927 were dead as of December,
1984

Vietnam:

615 West Virginia State
Vietnam veteran deaths
between 1968 and 1983

Vietnam: 3 STS/615 deaths
Non Vietnam: 0 STS/610
deaths

Holmes, et al.
(1986)

PMR

22

RESULTS

4 STS/927 deaths

Non Vietnam: 5 STS/1663
deaths

�AUTHORS

STUDY DESIGN

STUDY POPULATION

Wolf et al
(1985)

SMR

1260 Ranch Hand Personnel
who conducted aerial herbicide
spraying missions in Vietnam
from 1962 through 1971

0 STS/55 deaths

University of
Sydney
(1984)

SMR

10,205 Australian Vietnam
veterans, of which 260 were
dead as of January, 1982

Vietnam: 2 STS/260 deaths
Non Vietnam = STS/263
deaths

Rang, et al

Case Control

234 STS cases in the Patient
Treatment File

Odds ratio = 0.83 (95%
CI 0.63-1.09)

96 STS cases reviewed by the
AFIP

Odds ratio = 0.75
(95% CI 0.49-1.15)

RESULTS

SMR = Standardized Mortality Ratio; PMR = Proportionate Mortality Ratio; CI = Confidence Interval

23

�REFERENCES
1.

Anderson, H.A., Hanrahan, L.P., Jensen, M., et al.: 1986.
Wisconsin Vietnam veteran mortality study. Wisconsin Health
Department.

2.

Bailey, C., Baron, R.C., Basanac, E. et al.: 1986. West
Virginia Vietnam-era veterans mortality study. West
Virginia Health Department.

3.

Costa, J., Wesley, R.A., Rosenberg, S.A.: 1984. The
grading of soft tissue sarcomas. Results of a
clinicohistopathologic correlation in a series of 163 cases.
Cancer 53:530.

4.

Eilber, F.R., Morton, D.L., Eckhardt, J., et al.: 1984.
Limb salvage for skeletal and soft tissue sarcomas. Cancer
53:2579.

5.

Enneking, W.F.: 1983. Musculoskeletal Tumor Surgery,
Churchill Livingstone, New York, London.

6.

Enzinger, F.M., Lattes, R., Torloni, R.: 1969. Histological
typing of soft tissue tumors. International Histologicalj
Classification of Tumors No. 3., World Health Organization.

7.

Enzinger, F.M., Weiss, S.W.: 1983.
The C.V. Mosby Company, St. Louis.

8.

Eriksson, M., Hardell, L., Berg, N.O., et al.: 1981. Soft
tissue sarcomas and exposure to chemical substances: A
case-referent study. Br. J. Ind. Med. 38:27-33.

9.

Greenwald, P., Kovasznay, B.,Collins, D.N. et al.:
1984.
Sarcomas of soft tissues after Vietnam service. JNCI 73(5):
1107-1109.

10.

Halperin, E.C., Greenberg, M.S., Suit, H.D.: 1984. Sarcoma
of bone and soft tissue following treatment of Hodgkin's
disease.
Cancer 53:232.

11.

Hardell, L., Sandstrom, A.: 1979.
Case-control study:
tissue sarcoma and exposure to phenoxyacetic acids or
chlorophenols. Br. J. Cancer 39:711-717.

12.

Rang-, H.K., Weatherbee, L., Breslin, P.P.: 1986 Soft tissue
sarcomas and military service in Vietnam: A case comparison
group analysis of hospital patients. J. Occup. Med. 28(12):
1215-1218.

13.

Kim, J.H.:, Chu, F.C., Woodard, H.Q., et al.: 1978.
Radiation-induced soft tissue sarcoma and bone sarcoma.

24

Soft Tissue Tumors.

Soft

�Radiology 129:501.
14.

Kogan, M.D. and Clapp, R.W.: 1985. Mortality among Vietnam
veterans in Massachusetts, 1972-1983. Massachusetts
Department of Public Health.

15.

Lattes, R.: 1983. Tumors of soft tissues. Atlas of Tumor
Pathology, Second Series, Fascicle 1 (Revised), Armed Forces
Institute of Pathology.

16.

Lawrence, C.E., Reilly, A.A., Quickenton, P., et al.: 1985.
Mortality patterns of New York State Vietnam veterans. AJPH
75(3); 277-279.

17.

Mandard, A.M., Chasley, J., Mandard, J.C.: 1981. The
pathologist's role in a multidisciplinary approach for soft
tissue sarcoma. A reappraisal. J. Surg. Oncol. 1.69.

18.

Rosenberg, S.A., Tepper, J., Glatstein, E., et al.:
1982.
The treatment of soft tissue sarcomas of the extremities.
Ann Surg 196:305.

19.

Russell, W.O., Cohen, J., Enzinger, F.M., et al.: 1977.
clinical and pathological staging system for soft tissue
sarcomas. Cancer 40: 1562.

20.

Selikoff, I.J., Churg, J., Hammond, E.G.:
exposure and neoplasia. JAMA 188:22.

21.

Selikoff, I.J., Hammond, B.C.: 1979. Health hazards of
asbestos exposure. Ann NY Acad. Sci. 330:1.

22.

Tucker, M.A., Fraumeni, J.F.: 1982. Soft Tissue, in Cancer
Epidemiology and Prevention; Schottenfeld, D. and Fraumeni,
J.F.,: W.B. Saunders Co.

23.

Wolfe, W.H., Michalek, J.E., Miner, J.C., et al. 1985. An
epidemiologic investigation of health effects in Air Force
personnel following exposure to herbicides. Mortality
update-1985. Epidemiology Division, USAF School of
Aerospace Medicine, Brooks AFB, Texas.

25

1964.

A

Asbestos

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="17853">
              <text>056</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="17854">
              <text>1496</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="17856">
              <text>Series III Subseries II</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="17849">
                <text>Shepard, Barclay M.</text>
              </elementText>
              <elementText elementTextId="17850">
                <text>H. K. Kang</text>
              </elementText>
              <elementText elementTextId="17851">
                <text>F. M. Enziger</text>
              </elementText>
              <elementText elementTextId="17852">
                <text>L. B. Hobson</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="17855">
                <text>Typescript: Chapter 6: The Risk of Soft Tissue Sarcoma in Veterans of the Vietnam Conflict</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="17857">
                <text>VA/AFIP STSS</text>
              </elementText>
              <elementText elementTextId="17858">
                <text>Air Force Health Study</text>
              </elementText>
              <elementText elementTextId="17859">
                <text>state-funded Vietnam veterans study</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="2480" public="1" featured="0">
    <fileContainer>
      <file fileId="1339">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/3ce8147ab1c1296e66549f53f17ce898.pdf</src>
        <authentication>c6e5799d8a5ce0699630a79b6833b442</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63288">
                    <text>torn ID Number

01439

Author

Shepard, Barclay M.

Corporata Author
RODOrt/ArtiClB Titfe Typescript: Non-Hodgkin's Lymphoma: a Brief
Overview, March 31, 1987

Journal/Book Title
Year
Month/Day

March 31

Color

°

Number of Images

46

Descripton Notes

Tuesday, May 15, 2001

Page 1439 of 1514

�Non-Hodgkin's Lymphoma
A Brief Overview

The term non-Hodgkin's lymphoma refers to a group of
malignant neoplasms within the larger category of malignant
lymphomas. These tumors arise from the lymphoreticular system
which consits primarily of lymph nodes and collections of
specialized cells in many organs including the spleen, liver,
bone marrow, and portions of the gastrointestinal system. The
annual incidence of malignant lymphomas in the United States is
approximately 33,000 of which 25% are classified as Hodgkin's
disease and the remaining 75% are called non-Hodgkin's lymphoma.
The diagnosis of non-Hodgkin's lymphoma depends on a careful
microscopic examination of the actual tumor tissue and frequently
requires additional histo-chemical studies. There is a wide
range of cell types and the appropriate classification of a
particular tumor requires considerable skill on the part of an
experienced pathologist. Accurate diagnosis and correct
classification are very important since these determine the most
effective course of treatment and the prognosis of the tumor.
As is the case with many malignant neoplasms, the causative
factors for this group of tumors are largely unknown.
Considerable evidence does exist, however, that certain viruses
which have the potential for altering the immune system play a
key role in the development of certain types of non-Hodgkin 1 s
lymphoma. In addition, a number of recent epidemiological
studies are showing a positive association between non-Hodgkin's
lymphoma and exposure to chlorophenols and agricultural chemicals
such as the phenoxy acid herbicides and nitrogen-containing
fertilizers. It is too early to state that this represents a
definite cause-and-effect relationship, but the evidence seems to
be increasing to suggest such a conclusion.

Prepared by:

BARCLAY M. SHEPARD, M.D.
Director, Agent Orange Projects Office
March 31, 1987

�ABSTRACT

A population-based case-control study was conducted 1n western Washington
State to evaluate the relationship between occupational exposure of men aged
20 to 79 to phenoxy acetic acid herbicides and chlorinated phenols and the
risks of developing soft tissue sarcoma (STS) and non-Hodgkins lymphoma
(NHL). Occupational histories and other data were obtained by personal
interviews for 128 STS cases and 576 NHL cases, diagnosed between 1981 and
1984, and for 694 randomly selected controls without cancer. Among the study
subjects with any past occupational exposure to phenoxy herbicides, the
estimated relative risk and 952 confidence interval of developing STS was 0.80
(0.5-1.2), and of developing NHL, 1.07 (0.8-1.4). Risk estimates of
developing STS and NHL associated with past chlorophenol exposure were 0.99
(0.7-1.5) and 0.99 (0.8-1.2), respectively. No increasing risk of either
cancer was associated with overall duration or intensity of chemical exposure
or with exposure to any specific phenoxy herbicide per se. However, estimated
risks of NHL were elevated among men who had been fanners, 1.33 (1.03-1.7),
forestry herbicide applicators, 4.80 (1.2-19.4) and for those potentially
exposed to phenoxy herbicides in any occupation for 15 years or more during
the period prior to 15 years before cancer diagnosis, -1.71 (1.04-2.8).
Increased risks of NHL were also observed among those with occupational
exposure to organochlorine insecticides such as DDT, 1.82 (1.04-3.2), organic
solvents 1.35 (1.06-1.7), and to other chemicals typically encountered in the
agricultural, forestry or wood products industries. These results demonstrate
small but significantly increased risks of developing NHL in association with
some occupational activities involving exposure to phenoxy herbicides,
particularly for prolonged periods, and possibly in combination with other

Page 2

�chemicals. They do not demonstrate a positive association between increased
cancer risks and exposure to any specific phenoxy herbicide product alone.
Moreover, these findings provide no evidence of increased risks of developing
NHL associated with chlorinated phenol exposure or of developing STS
associated with exposure to either class of chemical.

Page 3

�INTRODUCTION
Recent studies from Sweden (1-5) and elsewhere (6-10) have reported an
increased risk of soft tissue sarcomas (STS) or non-Hodgkins lytnphomas (NHL)
in association with occupational exposures to phenoxy acetic acid herbicides
and/or chlorinated phenols.
appeared (11-15).

Negative studies of this association have also

Implicated as the putative carcinogen in most of these

studies is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS:1746-01-6), a trace
contaminant formed during the manufacture of chemicals which are derived from
alkaline hydrolysis of 1,2,4,5-tetrachlorobenzene.

Of particular concern in

this respect are 2,4,5-trichlorophenol and the phenoxy herbicides,
2,4,5-trichlorophenoxy acetic acid (2,4,5-T) (CAS:93-76-5) and
2-(2,4,5-trichlorophenoxy) propionic acid (Si!vex), which have been reported
to be contaminated with TCDD as high as 30 ppm (16).

Moreover, TCDD is the

prototype of a larger series of halogenated aromatic hydrocarbons including
other polychlorinated dibenzo-p-dioxins (PCDD), dibenzofurans and biphenyls,
all of which share similar biochemical properties and which may also
contaminate phenoxy herbicide or chlorophenol products in commercial use.
Hence, concern exists regarding the possible health risks from exposure to
chemical products in which any such contaminants may be present.
The present study was conducted to investigate the relationship between
the incidence of soft tissue sarcomas and non-Hodgkins lymphomas and past
exposure to phenoxy herbicides and chlorinated phenols using a
population-based case-control approach. Subjects were drawn from the male
population of western Washington state, where phenoxy acetic acid herbicides
and chlorophenols have been widely utilized during the past 40 years by
agricultural, forestry and wood products industries. Specific emphasis was
placed on identification of intervening factors or conditions which may

Page 4

�influence human susceptibility to the risk of cancer in association with
exposure to phenoxy acetic acids, chlorophenols or PCDDs.

METHODS
Acquisition of Cases and Controls
From 1983 through 1985 men with either STS or NHL were identified through
the Cancer Surveillance System (CSS), a population-based tumor registry that
has covered 13 counties of western Washington since 1974. Men eligible to
participate in the study were between the ages of 20 and 79 at diagnosis and
had been diagnosed during the years 1981-1984 as having either STS or NHL, as
classified histologically by the World Health Organization International
Classification of Diseases for Oncology, First Revision (17). Case
definitions of eligibility for STS by ICD-0 codes are 8800-8804, 8810-8813,
8830-8832, 8840, 8850-8860, 8890-8920, 8990-8991, 9040-9044, 9120, 9130, 9150,
9170, 9251, 9260, 9503, 9540-9560 and 9580-9581.

Case definitions of

eligibility for NHL by ICD-0 codes are 9590-9642, 9690-9701 and 9750. The CSS
obtains data from all hospitals throughout a 13 county region, and essentially
complete population coverage is attained.
During 1983-1985 a control group without STS or NHL was also selected.
Live control subjects aged 20-64 were chosen using a random digit dialing
procedure as described by Waksberg (18). Because the elderly are relatively
sparse in the general population, it was not economical to locate all older
controls by random digit dialing. Thus, additional live control subjects aged
65-79 were chosen at random from data supplied by the Health Care Financing
Administration covering social security recipients in the study area.
Controls were group-matched to NHL-cases by vital status and 5-year age group
with a ratio of 1.2 controls per case.

Deceased controls exclusive of

Page 5

�homicides and suicides were identified from non-cancer death certificates for
persons aged 20-79 with a date of death occurring during the study period and
with a residence within the 13-county study area.

The disposition of case and

control subjects according to vital status, interview outcome and pathologic
review of STS is presented in Table 1.
Interview Procedure
All study subjects, including proxies, were interviewed in-person by
experienced interviewers at a time and location of their choice. The
interview lasted approximately one hour and covered the participant's
residential, military and medical histories with a detailed section on
occupational exposures to herbicides, chlorophenols and other chemicals prior
to diagnosis or interview.

Detailed information on known or suspected risk

factors for STS and NHL including past history of immunosuppressive disorders,
use of immunosuppressant medication or family history of cancer or immune
disease, was also obtained.

Additional information, including pathology,

stage, extent of disease and date of diagnosis, was collected for each case
from data supplied by the CSS. "Exposure" for all variables refers to that
occurring prior to the date of diagnosis for the cases and prior to the date
of interview for controls. The effect of recall differences on cancer risk
owing to the difference in lapse time between diagnosis and interview for the
cases (about 1 year) versus initial contact and interview.for controls (about
1 month) was evaluated and found to be negligible. Risk estimates among
living and deceased cohorts were comparable for essentially all associations;
hence, living and deceased groups were combined in all analyses.
The questionnaire utilized in the interview was designed after identifying
the principal occupations and activities undertaken within the study area
which have involved the manufacture or use of phenoxy herbicides and/or

Page 6

�chlorophenols.
&lt;

Such occupations and activities were identified in

consultation with local industrial and university representatives who had had
long term experience with forestry, wood products and agricultural industries
in the Pacific Northwest. This consultation resulted in identification of 34
specific job titles (e.g., wood products worker, herbicide applicator) and 17
specific job activities (e.g., spray weeds with phenoxy herbicides;
manufacture chlorophenols) involving potential exposure to either phenoxy
herbicides or chlorophenols. In addition, 14 specific phenoxy herbicide or
chlorophenol preparations in common commercial use in the study area were
identified. Each job title or activity was then assigned to a "high,"
"medium," "low" or "no" exposure category for both phenoxy herbicides and
chlorophenols, reflecting the consensus of the consultant group of the likely
intensity of exposure to each chemical received in that occupation.

Examples

of occupational activities in each exposure category are given in the tables.
In the interview, cue questions referring to each specific job title,
activity or chemical preparation were asked to determine whether a subject had
worked in an occupation involving probable exposure to phenoxy herbicides or
chlorophenols. If an affirmative response to any cue question was elicited, a
series of additional inquiries was made to acquire detailed information
i

regarding the extent of exposure to specific chemicals of interest and the
precise time intervals during which each exposure episode had occurred. Among
the additional questions asked was an inquiry regarding the name and address
of the supervisor or a close co-worker in each job episode where possible
chemical exposure had occurred. This information was used with subject's
permission to corroborate self-reported exposure to specific chemicals and to
verify exposure histories in instances where the subject or his proxy was .
uncertain regarding the actual exposure circumstances in that job.

Paae 7

Additional

�measures taken to reduce the likelihood of recall bias with respect to the
reporting of phenoxy herbicide or chlorophenol exposure included avoiding a
deliberate focus on these specific chemicals in the interview and conducting
the interview during a period (1983-1985) of relatively low local or national
media attention to the herbicide-cancer issue. The study was not advertised
locally, and subjects were not made aware of the focus of the investigation
except that it had broad immplications with respect to environmental factors
related to cancer etiology.
In coding occupational exposure to phenoxy herbicides or chlorophenols
based on job descriptions, the inclusive dates during which a person was
employed in any specific occupation or activity were recorded in the
questionnaire. In the analysis, however, occupational exposure to phenoxy
herbicides and chlorophenols was considered to have begun no earlier than 1946
and 1937, respectively, the years when these chemicals first came into
widespread commercial use in the study area. The coding of each job episode
held by a study subject according to intensity and duration of exposure
permitted evaluation of the exposure history of each subject in terms of
duration of continuous or cumulative exposure at each dose level. Thus, a
complete exposure profile on each subject for each class of chemical under
evaluation was obtained.
Quality Control Procedures
Several quality control procedures were employed to verify the accuracy of
the data collected by interview. First, 145 respondents from a total of 1444
who completed interviews were randomly selected and were recontacted by
telephone approximately one month after the interview date.

Interview and

reinterview responses to 7 questions were compared. Five of the 7 questions
reflected an 88 percent or higher agreement with the original interview, and

�one item had an 81 percent agreement rate. The remaining item, cups of coffee
consumed per week, had a 34 percent agreement rate, although 55 percent of the
discrepancies involved minor disagreements regarding the precise number of
cups consumed.
A second quality control procedure consisted of independent receding of a
random sample of 238 coded interviews. The overall agreement rate between
codes and recedes was 99 percent. The agreement rate was 98.9 percent for
codes pertaining to phenoxy herbicides and 98.3 percent for codes pertaining
to chlorophenols.
Pathologic Review of Soft Tissue Sarcoma Case Materials
Pathologic review of histologic slides and/or sections prepared from
tissue blocks of STS cases was conducted in order to verify the initial
diagnosis of STS.

Reviews were performed by a pathologist (BK) with expertise

in soft tissue tumors.

For the review of STS, specimen materials were

acquired from each participating hospital where the initial diagnosis of STS
was made, and were then coded, and sent "blind" to the project pathologist.
In all, histoligic material from 155 cases was obtained for review. Twenty
percent of the slides or sections were resuomitted to the pathologist as an
internal check of his first diagnosis. In a few circumstances the project
pathologist disagreed with either the CSS or himself regarding the diagnosis
of either STS per se or the specific histological classification of STS.

In

these instances a sample of the disparate slides was sent to the Armed Forces
Institute of Pathology in Washington, DC for resolution of STS and/or
histologic type classification. This 3 tier STS evaluation procedure resulted
in retention of 45% of the STS cases in the study with histologic diagnosis as
originally determined, and an additional 34« of cases retained with STS
confirmed although of a different histologic classification than originally

Paae 9

�made. Twenty one percent of original cases were determined either not likely
to be STS, or of indeterminate pathology, and, consequently, were excluded
from the study. Many of these were primary bone tumors.

In light of the

widely accepted high level of reliability associated with the accurate
identification of NHL according to broad histologic classifications,
pathologic materials from NHL cases were not reviewed for verification in this
study.
Statistical Methods
The data analysis includes estimates of relative risks as odds ratios and
their 95* confidence intervals for a number of variables of interest.

The

most common confounding variable was age; thus, all relationships were
age-adjusted by 5 or 10-year age groups, where possible. Pooled odds ratios
were calculated using the Mantel-Haenszel method (19). Test-based confidence
intervals were calculated using the method of Miettinen (20).

In addition,

logistic regression analysis (21) was employed to evaluate the joint effect of
several variables and possible interactions between chemical exposure and
other potential risk factors on cancer risks. The total number of subjects
represented in each analysis varies according to the rate of unknown
responses; for occupational assessments unknowns were omitted from the
analyses. In all other analyses unknowns were included in the "none" or "no
exposure" category.

The percentage of the total study population responding

affirmatively with respect to specific job titles, exposures or other
characteristic is presented in the Tables. "Significance" in all analyses was
determined at the five percent level.

Paae 10

�RESULTS

Characteristics of the Study Population
Table 2 presents a comparison of NHL and STS cases and controls for
selected demographic attributes. The three groups were similar in most
respects. Notable differences included a higher proportion of STS cases than
controls among subjects in the 20-39 age group and a higher percentage of STS
cases in the "other" race category. Asians account principally for this
difference.
Risks Related to Intensity of Chemical Exposure
When estimates of relative risks of both STS and NHL were determined for
various levels of phenoxy herbicide or chlorophenol exposure among the entire
study population, no increasing trend nor risk estimates significantly
different from unity for any exposure level were seen (Table 3). However,
elevations in risk were observed for several specific occupations involving
chemical exposure. Estimates of relative risks of STS and NHL for various
occupations involving exposure principally to phenoxy herbicides are shown in
Table 4. When viewed across job categories involving increasing levels of
exposure, no clear indication of increasing risk is observed. No
significantly increased risks of either cancer were seen among those in
occupations involving low exposure to phenoxy herbicides, although a nearly
significant 1.70 (0.9-3.1) odds ratio for NHL was observed among landscapers.
Among those in medium exposure occupations, no significantly elevated
risks of STS were seen. A small but significantly increased risk of NHL, 1.33
(1.03-1.7), was observed among farmers, an occupation traditionally associated
with regular use of weed killers. This observation is consistent with reports
from other studies which have identified agricultural occupational groups at
increased NHL risk (22-25). Further evaluation of this observation with

Pace 11

�regard to duration of exposure and to use of specific substances indicated
that the risk of NHL increased from 1.02 (0.7-1.5) among those working as
fanners from 1 to 9 years to 1.62 (0.9-2.9) among farmers with 10 to 19 years
in that occupation.

However, no increased risks of developing NHL were

observed among those with more than 20 years as farmers, 0.92 (0.5-1.6).
Additionally, there were no increased risks of NHL among farmers who reported
having "regularly worked with" 2,4-D (0.68 [0.3-1.4]), 2,4,5-T (0.74
[0.3-2.1]), or phenoxy herbicides per se (0.71 [0.3-1.5]) when compared with
study subjects reporting no phenoxy herbicide exposure.

The estimated risk of

developing NHL among farmers who reported having regularly sprayed weed
killers by knapsack, tractor or aircraft was 1.13 (0.7-1.9). A risk of
developing NHL equal to 1.46 (0.8-2.8) was observed among farmers who reported
having worked with the specific organochlorine insecticides DDT and chlordane.
In occupations associated with high herbicide exposure, none was
associated with a statistically significant increased risk of developing STS.
A substantially increased risk of developing NHL, 4.80 (1.2-19.4), was noted
for persons who claimed to have worked regularly in jobs involving spraying of
weed killers in national, state or commercial forests.

However, increased

risks of this magnitude were not observed among those engaged in other
herbicide spraying activities or among those who worked as herbicide
f emulators or applicators per se. Further evaluation of-the increased risk
of NHL observed among forestry herbicide sprayers with respect to specific
chemicals used and duration of exposures indicated that all forestry sprayers
reported the combined use of 2,4-D and 2,4,5-T as well as various commercial
herbicide preparations containing these and other chemicals. An infinite risk
estimate was attained for developing NHL among forestry herbicide applicators
specifically in association with phenoxy herbicide exposure, inasmuch as tnere

Paae 12

�were no control subjects who served as forestry herbicide sprayers and did not
use phenoxy herbicides.
p = 0.004.
involved.

This association was statistically significant with

However, only a very small number of exposed subjects (7) were
The risks of STS and NHL associated with all occupations involving

potential exposure to phenoxy herbicides considered together were 0.80
(0.5-1.2) and 1.07 (0.8-1.4), respectively.

The risks of developing NHL

associated with exposure specifically to 2,4-D and 2,4,5-T and to phenoxy
herbicides in general among the entire study population were 0.73 (0.4-1.3),
0.98 (0.5-2.0) and 0.87 (0.5-1.5), respectively.
Table 5 presents risk estimates of STS and NHL for various occupations and
activities involving chlorophenol exposure.

As in the case of phenoxy

herbicides, no clear indication of increasing risks of either STS or NHL is
apparent when viewed across job categories involving increasing levels of
exposure to chlorophenols.

Somewhat elevated risks of developing STS are

suggested for lumber graders, 2.66 (1.1-6.4), and log/lumber inspectors, 4.83
(0.6-38.2), although other jobs involving comparable chlorophenol exposure
offer no suggestion of substantially increased STS risks.

No specific jobs

involving chlorophenol exposure were associated with increased risks of
developing NHL. When all occupations involving potential exposure to
chlorophenols were considered together, the risks of developing STS and NHL
were 0.99 (0.7-1.5) and 0.99 (0.8-1.2), respectively.
Results of Supervisor/Co-worker Survey
Corroboration of self-reported occupational exposure to phenoxy
herbicides, chlorophenols and other chemicals was sought through telephone
contact with employer supervisors or co-workers of subjects who had been
employed in jobs involving potential exposure to such substances.
Confirmation of subjects' responses regarding exposure was provided in

, Paae 13

�essentially all instances where employers or co-workers could be reached.
There were no significant differences between agreement rates for cases or
controls. The ability to acquire corroborative evidence of exposure (about
802 of contacts attempted) was greatest for most recent occupations held.
Risks Related to Duration of Chemical Exposure
Inasmuch as cancer risks may vary with length of exposure to specific
carcinogens or tumor promoting agents, it was of interest to estimate the
relative risks of STS and NHL for various lengths of cumulative exposure to
either phenoxy herbicides or chlorophenols. Hence, risk estimates of both
cancer types for 10-year durations (1-10, 11-20, 20+) of exposure to phenoxy
herbicides or chlorophenols were calculated. In this context, "exposure"
refers to any level of occupational phenoxy or chlorophenol exposure during
any portion of the time period since 1946 or 1937, respectively, up to the
date of diagnosis (cases) or interview (controls). "Duration" refers to the
total length of cumulative exposure during this time period. From these
calculations, it was determined that the risk of neither STS nor NHL increased
with the duration of phenoxy herbicide or chlorophenol exposure for periods of
20 years or more when all levels of exposure are considered concomitantly.
Moreover, no increased risks of either cancer were seen when increasing
lengths of exposure to only high levels of phenoxy herbicides or chlorophenols
were considered.
Evaluation of a Latency Period for Cancer Development
The average latency period for a carcinogenic effect of aromatic
hydrocarbons in humans has been postulated to be on the order of 15 to 30
years (26).

It was, therefore, of interest to determine if exposure to either

phenoxy herbicides or chlorophenols prior to an assumed latency period of 15
years before cancer diagnosis was associated with an increased risk of STS or

Page 14

�NHL. For these determinations, the risks of each cancer type were calculated
for two durations of cumulative exposure (1-14 and 1 5+ years) during the
period between 1946 or 1937 for phenoxy herbicides and chlorophenols,
respectively, and 15 years prior to diagnosis or interview.

The results

revealed a significant increase in the risk of NHL, 1.71 (1.04-2.8), among
those with cumulative exposures to phenoxy herbicides of more than 15 years
during the period preceding 15 years before diagnosis. When a 5 year latency
period for cancer development was assumed, the risk of NHL among those with 15
or more years of prelatency phenoxy exposure dropped to 1.29 (0.9-2.0). In
contrast, the risk of developing NHL was 2.51 (0.5-13.0) among subjects with
more than 15 years of herbicide exposure prior to a 25 year assumed latency
period. No increased risks of STS for either chemical or of NHL for
chlorophenols were observed in relation to chemical exposure for any latency
period or cummulative exposure assumption.
Evaluation of Other Risk Factors for STS and NHL
Since autoimmune diseases, primary immunodeficiency syndromes and other
conditions which compromise immune competence may act as independent risk
factors of STS or NHL, it was of interest to determine the risks of either
type of cancer associated with such conditions existing prior to the year of
cancer diagnosis (or interview). Table 6 presents risk estimates of STS and
NHL for a number of such conditions or factors. All assessments were made
from subject interviews, not from medical records. Immunosuppressant drug
therapy received for any reason prior to the year of diagnosis of NHL was the
greatest risk factor for either cancer.

Immune defficiency in a blood

relative was also associated with an increased (although non-significant) risk
of NHL. In contrast, the use of corticosteroids for observed periods of use
up to 29 years was not associated with an increased risk of either cancer type.

Paqe 15

�Of specific note is the 1.38-fold increased risk of NHL observed in
relation to a history of rheumatoid arthritis.

Although not statistically

significant, this observation is interesting in light of the current
controversy surrounding the question of increased risks of NHL among persons
afflicted with autoimmune diseases (27).

Preexisting skin cancer was also

associated with a slightly increased risk of both STS and NHL. Although the
type of skin cancer was not ascertained in this study, several histological
types of STS and NHL can have dermal manifestations which could have been
misreported as "skin cancer". Among these are the soft tissue tumors,
dermatofibrosarcoma (8832/3) and Kaposi's sarcoma (9140/3), and the
non-Hodgkins lymphoma, mycosis fungoides (9700-9701/3).

Kaposi's sarcoma was

excluded from evaluation in this study, and none of those reporting skin
cancer was found to have this form of STS. Among those 12 STS cases reporting
a prior history of skin cancer, none was found to have dermatofibrosarcoma,
and among 53 NHL cases, none had confirmed mycoides fungoides.
Malaria was evaluated as a potential risk factor for STS and NHL in light
of studies suggesting an etiologic association between malarial infection and
the risks of developing sarcomas or lymphomas through mechanisms involving
plasmodial suppression of immune defenses against malignant diseases (28,29).
The risk of developing neither STS nor NHL was significantly elevated in
association with a self-reported prior history of malaria alone.
Finally, Table 7 presents risk estimates associated with various
occupational and/or lifestyle factors which were observed in the present study
to independently alter the risk of STS or NHL and which might, therefore, be
considered as potential modifiers of the effect of chemical exposure on cancer
risks.

Of particular note is the significantly increased risk of NHL seen

among men with previous exposure to organic solvents, lead or lead arsenate

Paae 16

�pesticides, and welding and metal fumes. The risk of NHL was also elevated
among men reporting previous exposure to the organochlorine insecticides,
chlordane and DDT. Also of note is the increased risk of both STS and NHL
observed among those reporting a prior incidence of chloracne.

Although this

condition was not clinically confirmed in this study, this observation is of
considerable interest inasmuch as chloracne is an important clinical
manifestation of exposure to high levels of chlorinated dibenzodioxins and
furans in humans (30). The statistical association of reported chloracne with
phenoxy herbicide exposure was of borderline significance (p &lt; 0.075) in this
study.

Neither cigarette -smoking nor coffee drinking was a risk factor for

either cancer.
Not shown in Table 7 are a number of other factors or conditions which
were also evaluated as potential risks factors, but for which no significant
or suggestive associations with either STS or NHL were found.

These include:

exposure to radiation, X-rays or radioactive materials; exhaust fumes from
motorized equipment; home use of phenoxy herbicides; residency near areas
sprayed with weed killers; TB vaccination; consumption of multiple vitamins;
eating fish caught in Puget Sound; and, use of alcohol.
Logistic regression analysis was employed to estimate the potential
interaction between phenoxy herbicides or chlorophenols and various other
single variables appearing in Tables 6 or 7 as well as others of interest.
Intervening variables for which the interaction with phenoxy herbicides or
chlorophenols were determined included:

organochlorine pesticides (DDT +

Chlordane), lead/lead arsenate, welding or metal fumes, inherited or acquired
diseases of the immune system, any prior cancer, prior skin cancer, home use
of phenoxy herbicides, family history of cancer, and family history of
diseases of the imnune system.

All analyses were controlled for age. Results

�of the logistic regression analysis for these variables confirmed the
magnitude of the risks shown in Tables 6 and 7.

None of the interactions

between chlorinated phenol or phenoxy herbicide exposure and these variables
was statistically significant, with the exception of that between phenoxy
herbicides and organic solvents as a risk factor for NHL. The odds ratio for
joint exposure compared with exposure to neither substance was 1.50 with a 95«
confidence interval of 1.03-2.18.

The odds ratio estimates from the model for

exposure solely to organic solvents or phenoxy herbicides were
non-significantly 1.12 and 0.85, respectively.

The significance of the joint

exposure in this case may be a result of the large number of comparisons made
in this study or, possibly, due to a genuine synergistic effect.
Positive although non-significant interactions were also observed between
exposure to-either phenoxy herbicides or chlorophenols and co- or preexisting
autoimmune diseases or immune deficiency syndromes when those listed on
Table 6 and others (mononucleosis, celiac sprue, Sjogrens syndrome) were
considered jointly.

This interaction was most notable with chlorophenols

where the odds ratio for joint exposure (compared with neither) was 1.40
(0.95-2.07), as compared with 0.91 (0.72-1.14) and 1.32 (0.99-1.78),
respectively, for chlorophenol or immune deficiency alone.

These observations

are worthy of note in light of the widely held theory (31) that the etiology
of malignant lyraphomas involves failure of immunoregulation in the face of a
persistent stimulus for lymphocyte proliferation.

In autoimmune diseases,

chronic antigenie stimulation is provided by the constant exposure to
self-antigens, whereas in primary immunodeficiency syndromes, recurrent
infections are the likely source for antigenic stimulation.

In contrast, T2DD

is well recognized as a suppressant of both humoral and cell-mediated immunity
in animals (32-34), and has been recently characterized as a depressant of

Paae 18

�cell-mediated immunity in humans during prolonged, low-level exposure ( 3 5 ) .
Immunosuppression by other PCDDs has also been described (36). The
possibility that the statistical interactions, however slight, observed in
this study between phenoxy herbicides or chlorophenols and immunosuppressive
disorders may have biological relevance with respect to the etiology of NHL in
humans, therefore, deserves further consideration.

DISCUSSION
The results of the present study demonstrate significantly increased risks
of developing NHL among men in occupations involving farming and forestry
herbicide spraying and for occupations involving.regular exposure to phenoxy
acetic acid herbicides for prolonged periods. However, neither phenoxy
herbicides nor chlorophenols alone appear to constitute a sufficient cause of
either NHL or STS when evaluated within a population residing in western
Washington state, since increased cancer risks were not observed for numerous
other occupations or activities involving comparable opportunity for exposure
to these substances. In this regard, the present findings are not consistent
with results of studies conducted in Swedish and other populations which
report consistent and substantially increased risks of both types of cancer in
association with occupational exposure to specific chlorophenols or phenoxy
acetic acids or to combinations of these chemicals.
In consfderation of possible reasons underlying the apparent lack of
consi stency between the results of Swedish studies and those conducted here
and elsewto?*:, three issues which have not received major attention with
regard to •Slis question include: (1) differences in the intensities or dosages
of chemicals received by workers in comparable occupational activities, (2)
differences in the extent of environmental (non-occupational) exposure to the

ha ae 1 9

�chemicals received by the respective study populations, and (3) differences
between study populations with respect to the proportional distribution of
other risk factors which in combination with phenoxy herbicides or
chlorophenols contribute causally to the cancers putatively associated with
chemical exposure alone.
In addressing the question of differences in dosages of chemicals received
by workers engaged in comparable job activities, it is likely that, should the
chemicals under investigation independently increase cancer risks in humans,
this effect should be more apparent among persons receiving higher dosages.
In considering this possibility as it pertains specifically to application of
phenoxy herbicides, it is known that spraying activities, as well as work in
sprayed areas, extend over substantially shorter periods of the year in Sweden
than occur in western Washington, owing largely to climatic differences in the
length of the growing season. Thus, Swedish workers participate in activities
in which phenoxy herbicide exposure is typically consolidated within a 2-3
month period annually, during which spraying activities involving intensive
herbicide exposures which extend over several consecutive weeks at a time are
not uncommon (1,37). In contrast, the annual spraying season in the Pacific
korthwest extends over 6 to 7 months, during which individual spraying
episodes usually span only a few days at a time and may be separated by weeks
or even months during which no spraying is performed. Such differences in
herbicide use patterns could conceivably lead to Swedish applicators receiving
appreciably higher cumulative exposures to biologically active substances than
occurs among workers engaged in less intensive use patterns, as supported by
several studies of this questions (38,39).
To analyze this possibility quantitatively, we have employed the
pharmacokinetic model developed by Gehring (40) from the oral study of 2,4,5-7

Paae 20

�in humans to calculate maximum absorbed daily dosages of herbicide received by
Swedish and American workers.

The workers in question engaged in activities

with comparable job description, namely, herbicide applicator using
tractor-drawn equipment.

Calculations, based on urinary herbicide

concentrations using data derived from studies of applicators under actual
field conditions (37,41), indicate that the maximum daily dose of 2,4,5-T
absorbed by American workers in an application operation involving 2
sprayings, 2 weeks apart, is in the range of 12 to 86 ug/kg of body weight,
with a mean maximum daily dose of 45 ug/kg.

In contrast, calculated maximum

daily dosages received by Swedish workers, doing the same type of work but
involving spraying for 3 to 4 hours/day over a consecutive 2 week period
ranged from 11 to 315 ug/kg, with a mean maximum daily dosage of 90 ug/kg.
Maximum daily dosages received by American workers involved in other modes of
herbicide application were backpack crew, 19-104 ug/kg; helicopter crew, 17-23
ug/kg; and mixers, 12-138 ug/kg.

These results suggest that maximum daily

dosages of herbicides received by Swedish applicators could substantially
exceed those received by American counterparts as well as those engaged in
other modes of spraying operations.

From the pharmacokinetic studies in

humans (40) it is known that 2,4,5-T is absorbed and excreted in the urine
with a half-life of about one day following a single oral exposure.

Moreover,

from measurements of urinary 2,4,5-T, the maximum dose which can be absorbed
on repeated exposures is estimated to be about 100 ug/kg/day, with the
expected maximum concentration in plasma of individuals receiving repeated
daily doses reaching a plateau after 3 days of such exposure. Based on these
considerations, the calculated mean maximum daily dose of 2,4,5-T received by
Swedish workers under the occupational circumstances described above (90
ug/kg) would approximate that required to produce the maximum plasma

Paae 21

�concentration of 2,4,5-T which could be sustained during spraying operations.
Thus, Swedish applicators would experience higher sustained tissue levels
during repeated frequent exposure episodes, as well as higher tissue
concentrations of any PCDDs or other contaminants which would be concomitantly
absorbed, than would be experienced by American counterparts, who receive
lower exposures on a more sporadic basis.
Although the implications of these calculations with respect to human
cancer risks are difficult to estimate, they are nevertheless of interest in
light of findings from recent studies of Swedish subjects (42) involving
analysis of PCDDs in abdominal fat from both cases of STS and NHL as well as
control subjects. These studies reported that cancer cases exposed to
phenoxy herbicides 16 to 31 years previously had levels of highly chlorinated
PCDDs significantly higher than control subjects unexposed to phenoxy
herbicides. Interestingly, no differences in case or control TCDD levels were
seen. These findings are consistent with the observations from both Swedish
(2) and Danish (7) studies of increased cancer risks among persons exposed to
phenoxy herbicides and chlorophenols which do not contain detectable levels of
TCDD per se, but which are most likely contaminated with a variety of other
chlorinated dibenzodioxins and furans (43,44), some of which have been shown
to have carcinogenic potential (45,46). Moreover, the capacity of TCDD, and
presumably its approximate isostereoisomers, to act as a cocarcinogen (47) and
a tumor promoter (48,49) have been well characterized. These properties are
highly dose-dependent.

Thus, the exposure of Swedish workers to potentially

higher concentrations of biologically active substances associated with the
use or manufacture of phenoxy herbicides or chlorinated phenols is a
consideration possibly consistent with the higher cancer risks observed in
studies on such subjects. A recent study by Hoar et al (25) showing that the

Page 22

�relative risk of NHL dramatically increased with the number of days of phenoxy
herbicide use per year among agricultural workers in the U.S. supports this
view.
Differences in risk estimates observed between this and the Swedish
studies might also be accounted for on the basis of variation in the extent of
non-occupational exposure received by the general populations in areas where
the studies were conducted. Several investigators (50,51) have recently
reported widespread contamination of the general population in the United
States and Canada with PCDDs and PCDFs, based on analysis of human fat
samples.

The findings indicate that, while higher levels of total dioxins and

other contaminants may be seen in some exposed persons, there is considerable
overlap in actual tissue concentrations of such substances between some
persons with confirmed occupational exposures and others who are not
previously known to have been exposed through job-related activities. These
observations suggest that epidemiologic studies conducted in areas where the
extensive use of phenoxy herbicides and chlorophenols has occurred may have
inadvertently included subjects who have experienced significant exposure to
the chemicals of concern outside of the occupational setting.

Should this be

the case, it is possible that estimates of actual risk based on recall of
occupational exposures alone may be underestimated, owing to non-differential
misclassification of subjects according to exposure status (52).
To estimate the extent to which non-occupational exposure to phenoxy
herbicides may have occurred"in the present investigation, we have evaluated
data from several air monitoring studies (53,54) conducted during the spraying
season in the Pacific Northwest. These data indicate that phenoxy acetic
acids as well as PCDDs can be transported in the atmosphere, either as vapor
or adsorbed on particles, for distances ranging from several hundred feet up

Paae 23

�to a mile from the application area (54), depending on weather conditions and
mode of dispersion. The maximum concentration of 2,4,5-T, for example, found
in 24-hour collections from sampling stations in one study (55) was 3.4
o
3
ug/m . Concentrations of up to 10 ug/m of other phenoxy herbicides have
been detected at sampling sites in agricultural regions of Washington state
3
(57). If it is assumed that a 70 kg person inhales 30 m of air per day, a
person residing in the proximity of a sprayed area could conceivably receive a
dosage of 2,4,5-T equal to 1.5 ug/kg/day during the spraying operation solely
from atmospheric sources. These levels are on the order of 10 to 50 times
less than those received from occupational sources, as described above, and
moreover, are received via a different route of exposure (inhalation versus
dermal), which could alter absorption rates appreciably. However, it is
noteworthy that 24% of STS cases, 23% of NHL cases and 21% of control subjects
in the present study responded positively to the question "Have you ever lived
in an area where weed spraying was routinely done by truck or airplane?",
suggesting that considerable population exposure to phenoxy herbicides and
their contaminants from environmental sources could have occurred over the 40
year exposure assessment period. Eliminating subjects who reported
residential or home use exposures to phenoxy herbicides or chlorophenols in
the present study did not alter the estimated risks of developing STS or NHL.
Hence, it is unlikely that bias due to such exposures could account for the
large differences in risk estimates observed between these and the Swedish
studies. Nevertheless, should phenoxy herbicides and/or their contaminants
increase the risk of cancer at environmental exposure levels, or, as recently
suggested, produce subclinical immune system alterations which may predispose
to such risks (35), it is possible that risk estimates based solely on
assessment of occupational exposures could be attenuated as a result of

Pace 24

�exposure misclassification. Confirmation of this possibility awaits further
investigations based on direct analysis of tissue chemical content or the
development of a reliable surrogate measure of past chemical exposure.
A third possible reason for a lack of consistency between the results of
this and the Swedish studies may be differences between the study populations
with respect to the proportional distribution of factors or conditions other
than chemical exposure which contribute to the cancers under evaluation. If,
for example, a specific inherited, lifestyle or environmental condition which
independently predisposes to increased risks of the cancer(s) associated with
chemical exposure is more prevalent among Scandinavians than among other
populations, increased cancer risks could be observed in the former group,
even if the prevalence of phenoxy herbicide or chlorophenol exposure were the
same or even less than that occurring elsewhere. In this regard it is
interesting to note in the present study that exposure to the insecticides,
DDT and lead arsenate, as well as to agricultural and industrial chemicals
such as organic solvents and welding/metal fumes are associated with
significantly increased risks of developing NHL (Table 7). Compromise of the
immune system (31), exposure to zoonotic viruses (24,57) and chronic mitogenic
stimuli (24,31) have also been suggested as etiologic factors for NHL.
The extent to which differences in the proportional distribution of such
factors between Swedish and the local study population might account for the
inconsistencies observed between the results of this and the Swedish studies
cannot be currently estimated, since neither the specific conditions which
modify the effects of chemical exposure on cancer risks nor their prevalence
among the respective populations have as yet been identified.

However,

information based on interview responses from existing studies (4) indicates
that Swedish populations may have had as much as twice tne frequency of

Paoe 25

�exposure to DDT (5.8-7.8? versus 3.8°*. locally) as well as to total
insecticides (14.6% versus 7.9%), and this higher exposure may underlie some
increased risk of developing cancer, particularly NHL, independently of or in
combination with the chemicals currently under study.

On the other hand, the

frequency of exposure to organic solvents, for which a small but significant
interaction with phenoxy herbicides was observed in this study, was
approximately equal (28.2% versus 29.9%) between Swedish and local study
populations. Similarly, the frequency of cigarette smoking, now or ever,
among Swedish and local study populations was comparable (71* versus 73%).
Little or no data are available regarding population differences in
nutritional, medical or other lifestyle factors which might serve as component
causes of STS or NHL or which modify the effect of chemical exposures on
cancer risks.
The prospect that inherited factors or conditions among Scandinavians
might contribute to increased risks of developing cancer in that population
when exposed to the chemicals under investigation is another possibility that
might account for differences in risk estimates observed. Although specific
studies of this question have as yet to be accomplished, laboratory
investigations have shown that the binding affinity of the TCDD receptor, as
we'll as subsequent receptor-mediated events, are genetically determined and
may vary considerably even among different strains of the same animal soecies
(58).

That such variations are also a characteristic of human geneaology is

suggested by recent studies (59) which demonstrate both the presence of the Ah
(TCDD) receptor in human lung as well as considerable heterogenity in the
human population in regard to lung Ah receptor concentrations.

Moreover,

evidence of heritable differences in aryl hydrocarbon hydroxylase induction
among humans (60) has been presented.

Recently, a hereditary predisposition

Pace 26

�for the development of STS has been described in tne study of Danish phenoxy
herbicide manufacturers (7). However, no attempt has been made to determine
the frequency of this condition among Scandinavian or other populations, or to
investigate the extent to which the presence of such a condition could modify
the effect of chemical exposure on cancer risks.
In the present investigation we have taken advantage of the fact that
approximately 6% of the population of the study area is of Scandinavian
heritage (61) to make a crude evaluation as to the extent to which this factor
(Scandinavian heritage) might constitute an increased risk of STS or NHL in
association with phenoxy herbicide or chlorophenol exposure.

For this

assessment, the surnames of all study subjects were segregated into
Scandinavian or "other" categories by a member of the University of Washington
Department of Scandinavian Languages and Literature who had expertise in
Scandinavian genealogy. Through this effort 169 subjects with Scandinavian
surnames were identified including 15 STS cases, 66 NHL cases and 88
controls. No increased cancer risks were associated with having Scandinavian
as compared with non-Scandinavian names. However, when the analysis was
restricted to Scandinavians only, the risk estimates for STS in relation to
past occupational chemical exposures were substantially greater than those
observed among the study population as a whole both for high level phenoxy
herbicide (2.8[0.5-15.6]) and high level chlorophenol (7.2[2.1-24.7])
exposures. These estimates are comparable in magnitude to those reported
among subjects in Swedish (1-5) and Danish (7) studies. Moreover, the
distribution of predominant histologic types of STS was comparable to that
reported from the Swedish studies (2). No increased risks of NHL in relation
to chemical exposures were observed among persons with Scandinavian surnames.
While the assignment of Scandinavian ancestry in these studies remains

�unconfirmed, the results are interesting inasmuch as they suggest that factors
specific to Scandinavian descent, as opposed to residency or occupation in
Scandinavian countries, may contribute to increased risks of STS when exposed
to the chemicals under evaluation in this study.

Further investigation of

this issue may be warranted to help resolve the inconsistency between Swedish
studies and those conducted elsewhere.
In conclusion, the results of the present investigation demonstrate
increased risks of NHL in several specific occupations in which phenoxy acetic
acid herbicides are employed, as well as for prolonged occupational exposure
to these substances.

However, they are not consistent with results from

Swedish and other studies reporting substantially increased risks of either
STS or NHL associated with phenoxy herbicides or chlorophenols as sole or
major component causes of these diseases. Since methods of study design and
analysis in this and the Swedish studies were similar in most respects, it is
possible that factors specific to the populations under evaluation account for
the inconsistencies observed.

Concerns which bear further consideration in

this regard include possible differences in the intensity or distribution of
chemical exposures between the study populations, and variations in the
proportional distribution of specific inherited, lifestyle and/or
environmental factors which modify the effect of chemical exposure on the
risks of cancer development.

�REFERENCES

(1) Hardell L, Sandstrom A. Case-control study: Soft-tissue sarcomas and
exposure to phenoxyacetic acids or chlorophenols.

Br J Cancer 1979;

39:711-717.

(2) Eriksson M, Hardell L, Berg NO, Moller T. Axel son 0. Soft-tissue sarcomas
and exposure to chemical substances: A case-referent study.

Br J Ind

Med 1981; 38:27-33.

(3) Hardell L, Eriksson M. Soft-tissue sarcomas, phenoxy herbicides, and
chlorinated phenols.

Lancet 1981; 2:250.

(4) Hardell L. Relation of soft-tissue sarcoma, malignant lymphoma and colon
cancer to phenoxy acids, chlorophenols and other agents.

Scand J Work

Environ Health 1981; 7:119-130.

(5) Hardell L, Eriksson M, Lenner P, Lundgren E. Malignant lymphoma and
exposure to chemicals, especially organic solvents, chlorophenols and
phenoxy acids: A case-control study.

Br J Cancer 1981; 43:169-176.

(6) Bishop CM, Jones AH. Non-Hodgkin's lymphoma of the scalp in workers
exposed to dioxins.

Lancet 1981; 1:369.

(7) Lynge E. A follow-up of cancer incidence among workers in manufacture of
phenoxy herbicides in Denmark.

Brit J Cancer 1985; 52:259-270.

Dana

�(8)

Fingerhut MA, Halperin WE. Dioxin exposure and sarcoma.

J Am Med Assoc

1983; 249:3176-3177.

(9)

Moses M, Selikoff IJ.
chlorinated phenols.

Soft tissue sarcomas, phenoxy herbicides, and
Lancet 1981; 1:1370.

(10) Ott MG, Holder BB, Olson RD. A mortality analysis of employees engaged in
the manufacture of 2,4,5-trichlorophenoxy acetic acid.

J Occup Med

1980; 22:47-50.

(11) Wiklund K, Holm LE.
forestry workers.

Soft tissue sarcoma risk in Swedish agricultural and
JNCI 1986; 76:229-234.

(12) Smith AM, Pearce NE, Fisher DO, Giles HJ, league CA, Howard, JK.

Soft

tissue sarcoma and exposure to phenoxy herbicides and chlorophenols in
New Zealand.

JNCI 1984; 73:1111-1117.

(13) Riihimaki V, Asp S, Pukkala E, et al.

Mortality and cancer morbidity

among chlorinated phenoxy acid applicators in Finland.

Chemosphere

1983; 12:775-784.

(14) Suskind R.

Long-term health effects of exposure to 2,4,5-7 and/or

contaminants.

its

Chemosphere 1983; 12:769.

(15) Pearce NE, Smith AM, Howard JK, Sheppard RA, Giles KJ, league CA.
Non-Hodgkin's lymphoma and exposure to phenoxy herbicides,
chlorophenols, fencing work, and meat works employment: a case-control
study.

Brit J Indust Med 1986; 43: 75-83.
Page 30

�(16) Rappe C, Buser, HR. Occupational exposure to polychlorinated dioxins
and dibenzofurans.

In Choudhary G. ed. Chemical Hazards in the

Workplace, Measurement and Control.

ACS Symposium Series Vol 149.

Washington ACS 1981, pp 319-342.

(17) International Classification of Diseases for Oncology.
1976.

First Edition,

World Health Organization, Geneva.

(18) Waksberg J.

Sampling methods for random digit dialing.

J Amer Stat Assn

1978; 73:40-46.

(19) Mantel N, Haenzel W.

Statistical aspects of the analysis of data from

retrospective studies of disease.

JNCI 1959; 22:219-748.

(20) Miettinen OS. Estimability and estimation in case-referent studies.
Am J Epid 1976; 103:226-235.

(21) Prentice RL. Use of the logistic model in retrospective studies.

Biometrics 1976; 32:597-606.

(22) Cantor KP.

Fanning and mortality from non-Hodgkins lymphonia: a

case-control study.

(23) Schumacher MC.

Int J Cancer 1982; 29:235-247.

Farming occupations and mortality from non-Hodgkins

lymphoma in Utah.

J Occup Med 1985; 27:580-584.

�(24) Pearce NE, Smith AH, Fisher DO. Malignant lymphoma and multiple myeloma
linked with agricultural occupations in a New Zealand cancer
registry-based study.

Amer J Epid 1985; 121:225-237.

(25) Hoar SE, Blair A, Holmes FF, Boysen CD, Robe! RJ, Hoover R, Fraumeni JF.
Agricultural herbicide use and risk of lymphoma and soft-tissue
sarcoma. J. Amer. Med. Assoc. 1986; 256:1141-1147.

(26) Hueper, WC, Conway WD. Chemical carcinogenesis and cancers. Springfield,
IL. Thomas 1964; pp 40-43.

(27) Prior P. Cancer and rheumatoid arthritis: epidemiologic considerations.
Amer J'Med 1985; 78(Suppl 1A):15-21.

(28) Hargis BJ, Malkiel S. Sarcomas induced by injection of simian virus 40
into neonatal CFW mice.

J. Natl. Cancer Inst. 1979; 63:965-967.

(29) Wedderburn N, Campa M, Tosta CE, Henderson DC. The effect of malaria on
the growth of two syngeneic transplatable murine tumors.

Ann Trop Med.

Parasitol 1981; 75:597-605.

(30) Moses M, Li!is R, Crow KD et al. Health status of workers with past
exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the manufacture of
2,4,5-tetrachlorophenoxy acetic acid: comparison of findings with and
without chloracne. Am J Ind fled 1984; 5:161-182.

Page 32

�(31) Robbins SL, Cotran RS, Kumar V. Diseases of white cells, lymph nodes,
and spleen, in Pathologic Basis of Disease Third edition.

WB Saunders,

Philadelphia 1984; pp 653-704.

(32) Zinkl J, Vos JG, Moore JA, Gupta BN.

Hematologic and clinical chemistry

effects of 2,3,7,8-tetrachlorodibenzo-p-dixoin in laboratory animals.
Env Health Perspect 1973; 5:111-118.

(33) Clarke DA, Gaul die J, Szewczuk MR, Sweeney G. Enhanced suppressor cell
activity as a mechanism of immunosuppression by 2,3,7,8tetrachlorodibenzo-p-dioxin.

Proc Soc Exptl Bio! Med 1981; 168: 290-299.

(34) Yecchi A, Sironi M, Canegrati MA, et al.

Immunosuppressive effects of

2,3,7,8-tetrachlorodibenzo-p-dioxin in strains of mice with different
susceptibility to induction of aryl hydrocarbon hydroxylase.

Toxicol

Appl Pharmacol 1983; 68:434-441.

(35) Hoffman RE, Stehr-Green PA, Webb RB, et al.

Health effects of long-term

exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

0 Amer Med Assoc 1986;

255:2031-2038.

(36) Holsapple MP, KcCay JA, Barnes DM. Immunosuppression without liver
induction by subchronic exposure to 2,7-dichlorodibenzo-p-dioxin in
adult female B5C3F1 mice. Toxicol Appl Pharmacol 1986; 83:445-455.

(37) Kolmodin-Hedman B, Erne K, Engqvist A. Testing of professional exposure
to phenoxy acids (2,4-D and 2,4,5-T). Arbete och Halsa, Vetenskaplig
1070; 17 ( i n Swedish).

�(38) Newton N, Norn's LA. Potential exposure of humans to 2,4,5-T and TCDD
in the Oregon coastal ranges.

Fund Appl Toxicol 1981; 1:339-346.

(39) Taskar PK, Das YT, Trout JR, Chattopadhyay SK, Brown HD. Measurement of
2,4-dichlorophenoxyacetic acid (2,4-D) after occupational exposure.
Bull Environ Contain Toxicol 1982; 29:586-591.

(40) Gehring PJ, Kramer CG, Schwetz BA, Rose JQ, Rowe, VK.

The fate of

2,4,5-trichlorophenoxyacetic acid (2,4,5-T) f o l l o w i n g oral
administration to man. Toxicol Appl Pharmacol 1973; 26:352-361.

(41) Leng ML, Ramsey JC, Braun WH.

Review of studies with

2,4,5-trichlorophenoxyacetic acid in humans including applicators under
field conditions.

ACS Symposium Series 182. 1982; pp 135-156.

(42) Hardell L, Axel son 0.
etiology of cancer.
Prevention.

Phenoxy herbicides and other pesticides in the
Some comments on the Swedish experiences in Cancer

Strategies in the Workplace.

University of California, San

Francisco, December 1984.

(43) Norstrom A, Rappe C, Lindall R, Baser HR. Analysis of some older
Scandinavian formulations of 2,^-dichlorophenoxy acetic arid and
2,4,5-trichlorophenoxy acetic acid for contents of chlorinated
dibenzo-p-dioxins and dibenzofurans.

Scand J Work Environ Health 1579;

5:375-378.

Page 34

�(44) Dickson, D. PCP dioxins found to pose health risks.

Nature 1980; 282:416.

(45) NIH Bioassay of 2,7-dichlorodibenzo-p-dioxin for possible
carcinogenicity.

Nat! Tox Pgm, Technical Report Series No. 123, 1979.

(46) NIH Bioassay of a mixture of 1,2,3,6,7,8 and
1,2,3,7,8,9-hexachlorodibenzo-p-dioxins for possible carcinogenicity
(gavage study).

Nat! Tox Pgm, Technical Report Series No. 198, 1980.

(47) Kouri RE, Rude TH, Joglekar R, Dansette PM, Jerina DM, Atlas SA,
Owens IS, Nebert DW.

2,3,7,8-Tetrachlorodibenzo-p-dioxin as carcinogen

causing 3-methylcholanthrene-initiated subcutaneous tumors in mice
genetically "nonresponsive" at Ah locus.

Cancer Res 1978; 38:2777-2783.

(48) Pi tot HC, Goldsworthy T, Campbell HA, Poland A.

Quantitative evaluation

of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of
hepatocarcinogenesis from diethylnitrosamine.

Cancer Res 1980;

40:3616-3620.

(49) Abernathy DJ, Green!ee WF, Huband JC, Boreiko CJ.
2,3,7,S-Tetrachlprodibenzo-p-dioxin (TCDD) promotes the transformation
of C3K/1071/2 cells.

Carcinogenesis 1985; 6: 651-553.

(50) Ryan JJ, Williams DT, Lau BP-Y, Sakuma T.
Dibenzofurans in the Total Environment II,
C. eds, Butterworth, MA 1984; pp 205-214.

In Chiorinoted Dioxins and
Keith LH, Choudhary G, Rappe

�(58) Gasiewicz TA. Evidence for a homologous nature of Ah receptors among
various mammalian species in Biological Mechanisms of Dioxin Action.
Banbury Report 18. Poland A, Kimbrough RD, eds., Cold Spring Harbor
Laboratory 1984; pp 161-175.

(59) Roberts EA, Golas CL, Okey AB. Ah receptor mediating induction of aryl
hydrocarbon hydroxylase: detection in human lung by binding of
2
2,3,7,8,-[H ] tetrachlorodibenzo-p-dioxin. Cancer Res. 1986;
46:3739-3743

(60) Nebert DW, Jensen NM. The Ah locus: genetic regulation of the metabo
of carcinogens, drugs and other environmental chemicals by cytochrome
P-450-mediated monooxygenases. CRC Crit. Rev. Biochem. 1979;
pp.401-437.

(61) 1980 Census of Population, Vol 1, Characteristics of the Population,
Chapter C, General Social and Economics Characteristics, Part 49
Washington, US Department of Commerce, August, 1983.

�Table 1.

A case-control study of soft tissue sarcoma (STS) and non-Hodgkins
lymphoma (NHL) in relation to phenoxy herbicide and chlorophenol
exposure in Western Washington: Subject disposition.

STS

Subject

NHL

Living

Disoosition

Dead

Controls

Living

N

%

N

%

150

-

56

-

U

%

Dead
K

Living
%

N

%

Dead
N

:

Total identified

as eligible
Physician refusal

20 13

Respondent refusal

43

527 - 219

-

7 13

80 15

23 11

24

1 5 3

84

622 - 288 -

9 5 15

2 9 10

51

4 0 14

Other reasons for
non-interview
Total Interviewed

6

4

120 80

4

7

43 77

24

5

10

5

408 77 178 81

8

476 77 219 76
I

Excluded by pathologic
review

'

21 18* 12 28*

Excluded as non-eligible
post-interview**

2 - 0 -

6 - 4 -

1

- 0

Total Subjects
for analysis

97 -

31

-

402 - 174

* Percent of Total interviewed
**Based on diagnosis, age, "residence or date of diagnosis.

-

475 - 219

-

�Table 2.

Selected characteristics of 128 STS case men, 576 NHL case men
(diagnosed 1981-1984) and 694 interviewed population control men
(1983-1985).

STS (?)

NHL (?)

Controls (?)

Age

20-29

28.1

10.9

10.2

40-59

29.7

34.4

34.0

60-79

42.2

54.7

55.8

Less than High. School

21.1

26.3

26.4

High School graduate

76.6

72.0

70.6

2.3

1.7

3.0

White

89.8

94.4

95.1

Black

2.3

2.1

2.3

Other

7.0

3.4

2.6

Unknown

0.8

0.0 .

0.0

Education

Unknown

Race

Annual Income Level
Less than 515,000/year

25.8

28.0

24.1

$15, 000-530, OOD/year

32.8

37.3

35.2

30,000+/year

33.6

*»«••• 0

34.3

Refused

3.9

0.5

0.7

Unknown

3.9

0.7

1.7

�Table 3.

Risk (pooled odds ratio) of developing STS or NHL in men aged
20-79 by estimated intensity of past occupational exposure to
phenoxy herbicides or chlorophenols:

128 STS cases and 576 NHL

cases (diagnosed 1981-1984) and 694 population control men
(interviewed 1983-1985)in Western Washington.

The percentage of

the total study population in each exposure category is also
presented.

PHENOXY HERBICIDES
EXPOSURE

STS

NHL

CATEGORY

OR (95? CI)

OR ( 5 CI)
9?

PERCENT
STUDY
POPULATION

None

1.0

1.0

63.3

Low

0.56 (0.3-1.1)

0.90 (0.6-1.3)

12.0

Medium

0.99 (0.6-1.7)

0.95 (0.7-1.3)

16.5

High

0.89 (0.4-1.9)

1.24 (0.6-1.9)

8.2

CHLOROPHENOLS
EXPOSURE

STS

NHL

CATEGORY

OR ( 5 CI)
9?

OR ( 5 CI)
9?

Pr.Rwr.KT
STUDY
POPULATION

None

1.0

1.0

41.5

Low

0.90 (0.5-1.6)

0.97 (0.7-1.3)

16.5

Medium

0.93 (0.6-1.5)

0.92 (C.7-1.2)

31.8

High

0.93 (0.5-1.8)

0.92 (0.9-1.4)

10.2

�Table 4.

Risk (pooled odds ratio) of developing STS or NHL in men aged 20-79 for
specific occupations and activities involving potential phenoxy
herbicide exposure:

128 men with STS and 576 men with NHL in Western

Washington (diagnosed 1981-1984) and 694 population control men
(interviewed 1983-1985).

The precentage of the total study population

in each occupation or activity is also presented.

PHENOXY HERBICIDES
OCCUPATION
OR
ACTIVITY

STS

NHL

OR (95£ CD

OR (9Si CD

PERCENT
STUDY
POPULATION

Low Exposure:
landscaper

0.92 (0.3-2.8)

1.70

(0.9-3.1)

3.6

railway worker

1.14 (0.6-2.2)

1.06 (0.7-1.5)

10.7

telephone lineman

0.73

1.28 (0.6-2.6)

2.4

0.83

6.1

(0.1-3.6)

Medium Exposure:

gardner/grou ndskeeper

1.07 (0.5-2.2)

fanner

1.25 (0.8-1.9)

working in sprayed area

1.34 (0.7-2.6)

1.33

herbicide forma lator/mixer

1.24 (0.3-5.3)

1.53 (0.7-313)

2.1

herbicide applicator

1.77 (0.5-5.6)

1.33 (0.8-3.9)

2.2

spraying herbicides from backpack

0.80 (0.3-2.4)

0.82

(0.4-1.5)

2.3

spraying herbicides from tractor
or aircraft

1.27 (C. 5-3.1)

1.51 (0.9-2.5)

4.9

spraying farmlands with herbicides

1.35 (0.5-2.3)

1.35 (C.8-2.4)

4.3

spraying forests with herbicides

- - --

*4.80 (1.2-19.4)

1.0

spraying near utility lines or
railroad tracks

_ _ _ _

(0.5-1.4)

*1.33 (1.03-1.7)
(0.9-2.0)

30.0
8.4 -

High Exposure:

* D

n nc

1.03

(0.3-3.1)

0.9

�CHLOROPHENOL

OCCUPATION
OR
ACTIVITY

STS

NHL

OR (95% CD

OR (95? CD

PERCENT
STUDY
POPULATION'

Low Exposure:

planer mill worker

1.55 (0.5-4.7)

1.39 (0.7-2.7)

3.1

feeder man

1.31 (0.4-4.7)

1.44 (0.7-2.81)

2.9

bander man

0.90 (0.2-4.4)

1.45 (0.6-3.4)

1.8

log/lumber inspector

4. 83 (0.6-38.2)

0.40

(0.0-3.6)

"0.4

sawmill worker

0.97 (0.5-1.8)

1.03 (0.7-1.4)

15.0

wood products worker

1.27 (0.7-2.3)

0.88 (0.6-1.3)

12.0

fork lift driver in mill

1.52 (0.6-3.6)

1.44 (0.8-2.6)

4.2

lumber grader

*2.66 (1.1-5.4)

0.94 (0.5-1.9)

3.1

wood preserver

0.79 (0.1-5.9)

1.64 (0.6-4.2)

1.4

manufacturer of chlorophenols

1.37 (0.4-4.3)

1.72 (0.9-3.4)

3.0

Medium Exposure:

High Exposure:

* P •* 0.05

Paoe 42

�Table 6.

Risks (pooled odds ratio) of developing STS and NHL among men aged 20-79
with factors or conditions associated with compromise of immune
competence:

128 men with STS and 576 men with NHL (diagnosed 1981-1984)

and 694 population controls (interviewed 1983-1985) in Western
Washington.

The precentage of the total study population with each risk

factor is also presented.

STS
RISK
FACTOR

Malaria

NHL

OR (95% CI

OR (95% CI)

PERCENT
STUDY
POPULATION

1.14 (0.4-3.1)

1.47 (0.9-2.5)

4.7

non-skin

0.88 (0.3-2.5)

1.24 (0.7-2.1)

4.8

skin

1.47 (0.7-3.1)

*1.57 (1.03-2.4)

7.5

0.70 (0.4-1.1)

0.91 (0.7-1.2)

27.5

Rheumatoid arthritis

1.38 (0.9-2.2)

5.9

Low gamma or immunoglobulin

1.59 (0.5-4.6)

1.0

*10.97 (2.1-57.3)

0.7

1.51 (0.4-5.6)

0.6

Preexisting Cancer:

Corticosteroids

Imnunosuppressant drug therapy**
Immune deficiency in a
blood relative

* P &lt;0.05
** Azathioprine, Cyclophosphamide, Chlorambucil and/or Mercaptopurine.

�Table 7.

Risks (pooled odds ratio) of developing STS and NHL among men aged 20-79
associated with nicellaneous occupational factors or conditions among
128 men with STS and 576 men with NHL (diagnosed 1981-1984} and 694
population controls (interviewed 1983-1985) in Western Washington. The
precentage of the total study population with each condition or factor
is also presented.

STS
CONDITION

NHL

OR (95* CI)

OR (95% Ci:

PERCENT
STUDY
POPULATION

Insecticides:
Chlordane

0.96 (0.2-4.8)

DDT

1.10 (0.4-3.2) *1.82 (1.04-3.2)

1.61 (0.7-3.8)

1.6
4.0

Industrial Chemicals:
Organic solvents

1.10 (0.7-1.7)

*1.35 (1.06-1.7)

29.8

lead/lead arsenate

1.51 (0.9-2.6)

*1.60 (1.1-2.3)

12.0 •

welding/metal fumes

1.30 (0.9-2.0)

*1.31 (1.03-1.7)

31.1

Chloracne

3.32 (0.8-14.0)

2.12 (0.6-7.0)

1.0

Skin blisters from chemicals

1.72 (0..9-3.2)

1.06 (0.7-1.6)

7.8

Cigarette smoking

0.93 (0.6-1.4)

0.85 (0.7-1.1)

73.5

Coffee drinking

0.49 (0.4-1.2)

1.28 (0.9-1.9)

8°.8

* P &lt; 0.05

�Table 7.

Risks (pooled odds ratio) of developing STS and NHL. among men aged 20-79
associated with micellaneous occupational factors or conditions among
128 men with STS and 576 men with NHL (diagnosed 1981-1984) and 694
population controls (interviewed 1983-1985) in Western Washington. The
precentage of the total study population with each condition or factor
is also presented.

STS

CONDITION

NHL

OR (95* CD

OR (95£ CD

PERCENT
STUDY
POPULATION

Insecticides:
Chlordane

0.96 (0.2-4.8)

1.61 (0.7-3.8)

1.6

DDT

1.10 (0.4-3.2)

*1.82 (1.04-3.2)

4.0

Organic solvents

1.10 (0.7-1.7)

*1.35 (1.06-1.7)

29.8

lead/lead arsenate

1.51 (0.9-2.6)

*1.60 (1.1-2.3)

12.0

welding/metal fumes

1.30 (0.9-2.0)

*1.31 (1.03-1.7)

31.1

Chloracne

3.32 (0.8-14.0)

2.12 (0.6-7.0)

1.0

Skin blisters from chemicals

1.72 (0..9-3.2)

1.06 (0.7-1.6)

7.8

Cigarette smoking

0.93 (0.6-1.4)

0.85 (0.7-1.1)

73.5

Coffee drinking

0.49 (0.4-1.2)

1.28 (0.9-1.9)

89.8

Industrial Chemicals:

* P &lt; 0.05

�FOOTNOTES

1.

Supported by U.S. Public Health Service Grant CA-29900.

2.

We are indebted to the staff of the Epidemiologic Research Unit of the
Fred Hutchinson Cancer Research Center for their assistance in the
conduct of this study.

3.

We gratefully thank Frans M. Enzinger, M.D., Chairman, Department of
Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington,
DC, for assisting in the confirmation and histological classification of
soft tissue sarcoma case materials in this study.

i

/! r

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="17383">
              <text>054</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="17384">
              <text>1439</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="17386">
              <text>Series III Subseries II</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="17382">
                <text>Shepard, Barclay M.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="17385">
                <text>Typescript: Non-Hodgkin's Lymphoma: a Brief Overview, March 31, 1987</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="17387">
                <text>soft tissue sarcoma</text>
              </elementText>
              <elementText elementTextId="17388">
                <text>lymphomas</text>
              </elementText>
              <elementText elementTextId="17389">
                <text>DDT</text>
              </elementText>
              <elementText elementTextId="17390">
                <text>health studies</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="2105" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="13608">
              <text>043</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="13610">
              <text>1052</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="13614">
              <text>Series III Subseries I</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13607">
                <text>Shepard, Barclay M.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13609">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;Veterans Administration</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="13611">
                <text>Accidental Exposure to Dioxins: Human Health Aspects</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13612">
                <text>1983</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13613">
                <text>Health-Related Problems to TCDD</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13615">
                <text>VA</text>
              </elementText>
              <elementText elementTextId="13616">
                <text>veteran health and hygiene</text>
              </elementText>
              <elementText elementTextId="13617">
                <text>Southeast Asia</text>
              </elementText>
              <elementText elementTextId="13618">
                <text>health studies</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="2104" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="13596">
              <text>043</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="13598">
              <text>1051</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="13602">
              <text>Series III Subseries I</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13594">
                <text>Shepard, Barclay M.</text>
              </elementText>
              <elementText elementTextId="13595">
                <text>A. L. Young</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13597">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;Office of Environmental Medicine, Veterans Administration</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="13599">
                <text>Human and Environmental Risk of Chlorinated Dioxins and Related Compounds</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13600">
                <text>1983</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13601">
                <text>Dioxins as Contaminants of Herbicides: The U.S. Perspective</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13603">
                <text>herbicide damage assessment</text>
              </elementText>
              <elementText elementTextId="13604">
                <text>study protocol</text>
              </elementText>
              <elementText elementTextId="13605">
                <text>Southeast Asia</text>
              </elementText>
              <elementText elementTextId="13606">
                <text>veteran health and hygiene</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
